<SEC-DOCUMENT>0000721371-17-000017.txt : 20170207
<SEC-HEADER>0000721371-17-000017.hdr.sgml : 20170207
<ACCEPTANCE-DATETIME>20170207164436
ACCESSION NUMBER:		0000721371-17-000017
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		10
FILED AS OF DATE:		20170207
DATE AS OF CHANGE:		20170207
EFFECTIVENESS DATE:		20170207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDINAL HEALTH INC
		CENTRAL INDEX KEY:			0000721371
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				310958666
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-215935
		FILM NUMBER:		17579606

	BUSINESS ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147573033

	MAIL ADDRESS:	
		STREET 1:		7000 CARDINAL PLACE
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDINAL DISTRIBUTION INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>forms-3asrfeb2017.htm
<DESCRIPTION>FORM S-3ASR
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s4FFCC23C9E58E8BBD74CFB26AD492DE1"></a></div><div><div style="line-height:120%;text-align:justify;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:24%;"></td><td style="width:51%;"></td><td style="width:25%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="vertical-align:top;text-align:left;font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;vertical-align:top;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;vertical-align:top;">Table of Contents</font></a></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">As filed with the Securities and Exchange Commission on February 7, 2017</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;">Registration No. 333-</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:100%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:100%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">Washington,&#160;D.C. 20549</font></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">FORM S-3 </font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;font-weight:bold;">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font></div><div style="line-height:120%;text-align:center;font-size:20pt;"><font style="font-family:Arial Narrow;font-size:20pt;font-weight:bold;">Cardinal Health, Inc.</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Ohio</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">31-0958666</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;vertical-align:middle;font-size:7pt;"><font style="font-family:Arial Narrow;font-size:7pt;font-style:italic;font-weight:bold;vertical-align:middle;">(State or other jurisdiction of</font></div><div style="text-align:center;vertical-align:middle;font-size:7pt;"><font style="font-family:Arial Narrow;font-size:7pt;font-style:italic;font-weight:bold;vertical-align:middle;">incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial Narrow;font-size:7pt;font-style:italic;font-weight:bold;">(I.R.S. Employer</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial Narrow;font-size:7pt;font-style:italic;font-weight:bold;">Identification Number)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">7000 Cardinal Place</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Dublin, Ohio 43017</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">(614)&#160;757-5000</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial Narrow;font-size:7pt;font-style:italic;font-weight:bold;">(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Jessica L. Mayer</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Senior Vice President, Deputy General Counsel and Corporate Secretary</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">7000 Cardinal Place</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Dublin, Ohio 43017</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">(614)&#160;757-5000</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial Narrow;font-size:7pt;font-style:italic;font-weight:bold;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial Narrow;font-size:8pt;font-style:italic;font-weight:bold;">Copies to:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Andrew Fabens</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">John M. Adams, Jr.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Gibson, Dunn &amp; Crutcher LLP</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Associate General Counsel</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">200 Park Avenue</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Cardinal Health, Inc.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">New York, New York 10166</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">7000 Cardinal Place</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">(212) 351-4000</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Dublin, Ohio 43017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">(614)&#160;757-5000</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Approximate date of commencement of proposed sale to the public: </font><font style="font-family:Arial Narrow;font-size:9pt;">From time to time after this registration statement becomes effective.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.&#160;</font><font style="font-family:Wingdings;font-size:9pt;">o</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. </font><font style="font-family:Wingdings;font-size:9pt;">&#254;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160; </font><font style="font-family:Wingdings;font-size:9pt;">o</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. </font><font style="font-family:Wingdings;font-size:9pt;">o</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">If this Form is a registration statement pursuant to General Instruction&#160;I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box. </font><font style="font-family:Wingdings;font-size:9pt;">&#254;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction&#160;I.D. filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. </font><font style="font-family:Wingdings;font-size:9pt;">o</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.3952802359882%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:20%;"></td><td style="width:3%;"></td><td style="width:43%;"></td><td style="width:3%;"></td><td style="width:25%;"></td><td style="width:3%;"></td><td style="width:3%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Large&#160;accelerated&#160;filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Wingdings;font-size:9pt;">&#254;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Accelerated&#160;filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Non-accelerated filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:Wingdings;font-size:9pt;">o</font><font style="font-family:Arial Narrow;font-size:9pt;">&#160;(Do not check if a smaller reporting company)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Smaller&#160;reporting&#160;company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90167158308752%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:28%;"></td><td style="width:16%;"></td><td style="width:24%;"></td><td style="width:16%;"></td><td style="width:16%;"></td></tr><tr><td colspan="5" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="vertical-align:middle;text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;vertical-align:middle;">CALCULATION OF REGISTRATION FEE</font></div><div style="text-align:center;vertical-align:middle;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Title of each class of</font></div><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">securities to be registered</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Amount to be</font></div><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">registered (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Proposed maximum</font></div><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">offering price per unit (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Proposed maximum</font></div><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">aggregate offering price (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">Amount of</font></div><div style="text-align:center;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;font-weight:bold;">registration fee (1)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Common Shares, without par value</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Preferred Shares, without par value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">Debt Securities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:9pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:Arial Narrow;font-size:9pt;">There are being registered hereunder such presently indeterminate number or principal amount of Cardinal Health, Inc. debt securities, common shares and preferred shares as may from time to time be issued at indeterminate prices.  Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities.  In accordance with Rules&#160;456(b) and 457(r), the registrant is deferring payment of all of the registration fee.</font></div></td></tr></table><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s687233CDE6C40888CE6FFB26A802AB0B"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><img src="coverpicture14a04.jpg" alt="coverpicture14a04.jpg" style="height:78px;width:192px;"><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">COMMON SHARES</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">PREFERRED SHARES</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">DEBT SECURITIES</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health may offer and sell from time to time, together or separately, the following securities:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">common shares,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">preferred shares,</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">unsecured debt securities,&#160;or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any combination of these securities.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We will provide the terms of any offering and the specific terms of the securities offered in supplements to this prospectus.  You should read this prospectus and any accompanying prospectus supplement carefully before you invest.  This prospectus may not be used to sell any of these securities unless accompanied by a prospectus supplement or term sheet.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">See &#8220;Risk Factors&#8221; beginning on page 3 for a discussion of certain risks that you should consider in connection with an investment in Cardinal Health&#8217;s securities.</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health&#8217;s common shares are listed on the New York Stock Exchange under the symbol &#8220;CAH.&#8221;</font></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete.  Any representation to the contrary is a criminal offense.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The date of this prospectus is February 7, 2017.</font></div><div style="line-height:120%;text-align:center;padding-left:46px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><hr style="page-break-after:always"><div><a name="s89C002B2989B396915D4FB26AD9D1CF5"></a></div><div></div><div><br></div><div style="line-height:120%;text-align:center;padding-left:46px;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;background-color:#ffffff;font-weight:bold;">TABLE OF CONTENTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:95%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Page</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sFE95219A6A152D68E57CFB26ADEFC39D"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">ABOUT THIS PROSPECTUS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sFE95219A6A152D68E57CFB26ADEFC39D">1</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sF0AB831397BC86CD12C2FB26AE2151B5"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">WHERE YOU CAN FIND MORE INFORMATION AND INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sF0AB831397BC86CD12C2FB26AE2151B5">2</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s26B0028744A0EB642B3AFB26AE432426"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">RISK FACTORS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s26B0028744A0EB642B3AFB26AE432426">3</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sC4BF69A82F66096016C4FB26AE75666F"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sC4BF69A82F66096016C4FB26AE75666F">4</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sE88299F372D064AEE7F2FB26AE9E823E"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">THE COMPANY</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sE88299F372D064AEE7F2FB26AE9E823E">7</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sA298B3981B30DB69E95EFB26AEC9059C"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">USE OF PROCEEDS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sA298B3981B30DB69E95EFB26AEC9059C">8</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sE3F2A867244F1FD0157EFB26AEEA9A24"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">RATIO OF EARNINGS TO FIXED CHARGES</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sE3F2A867244F1FD0157EFB26AEEA9A24">9</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s90E4813633295E86061BFB26AF1C66EB"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">DESCRIPTION OF CAPITAL STOCK</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s90E4813633295E86061BFB26AF1C66EB">10</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#sB471F5A0D00C6490ACA7FB26AF3F9FBD"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">DESCRIPTION OF DEBT SECURITIES</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#sB471F5A0D00C6490ACA7FB26AF3F9FBD">12</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s608C36D51CD947A2D978FB26AF8FFA32"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">VALIDITY OF THE SECURITIES</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s608C36D51CD947A2D978FB26AF8FFA32">24</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s8E9AC3896C99C7463FB5FB26AF9A3FD0"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">EXPERTS</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s8E9AC3896C99C7463FB5FB26AF9A3FD0">25</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;" href="#s2395976A03571BC05242FB26AFC29352"><font style="font-family:Arial Narrow;font-size:10pt;color:#0000ff;text-decoration:underline;">PLAN OF DISTRIBUTION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;" href="#s2395976A03571BC05242FB26AFC29352">26</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">EX 5.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">EX 5.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">EX 23.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">EX 25</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:100%;padding-top:14px;text-align:left;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sAC28D47A825DA1294034FB26ADCF7A43"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:1pt;"><font style="font-family:Arial Narrow;font-size:1pt;"><br></font></div><div><a name="sFE95219A6A152D68E57CFB26ADEFC39D"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">ABOUT THIS PROSPECTUS</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) using a &#8220;shelf&#8221; registration process.  Under this shelf process, Cardinal Health may sell in one or more offerings any combination of Cardinal Health&#8217;s common shares, preferred shares, unsecured debt securities in one or more series, which may be senior or subordinated debt securities, or any combination of these securities.  This prospectus provides you with a general description of the securities Cardinal Health may offer.  Each time Cardinal Health sells securities, we will provide a prospectus supplement, which may be in the form of a term sheet, that will contain specific information about the terms of that offering and the specific terms of the securities.  The prospectus supplement may also add, update or change information contained in this prospectus, and accordingly, to the extent inconsistent, information in this prospectus is superseded by the information in the prospectus supplement.  You should read both this prospectus and the applicable prospectus supplement together with additional information described under the heading &#8220;Where You Can Find More Information and Incorporation of Certain Documents by Reference.&#8221;</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Because Cardinal Health is a "well-known seasoned issuer," as defined in Rule&#160;405 of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), Cardinal Health may add to and offer additional securities, including securities to be offered and sold by selling security holders, by filing a prospectus supplement with the SEC at the time of the offer.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We have not authorized any person to provide you with any information or to make any representation other than as contained in this prospectus or in any prospectus supplement and the information incorporated by reference herein and therein.  We do not take any responsibility for, and can provide no assurance as to the reliability of, any information that others may give you.  Cardinal Health is not making an offer to sell or a solicitation of an offer to buy these securities in any jurisdiction where the offer, sale or solicitation is not permitted.  The information appearing or incorporated by reference in this prospectus and any supplement to this prospectus is accurate only as of the date of this prospectus or any supplement to this prospectus or the date of the document in which incorporated information appears.  Our business, financial condition, results of operations and prospects may have changed since those dates.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Unless otherwise indicated or unless the context otherwise requires, all references in this prospectus to &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Cardinal Health, Inc. and its consolidated subsidiaries, and references to &#8220;Cardinal Health&#8221; or "the Company&#8221; refer to Cardinal Health, Inc., excluding its consolidated subsidiaries.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div><a name="sF0AB831397BC86CD12C2FB26AE2151B5"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">WHERE YOU CAN FIND MORE INFORMATION AND </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC.  The SEC maintains an Internet site at http://www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC.  You may also read and copy any materials we file with the SEC at the SEC&#8217;s public reference room at 100 F Street, N.E., Washington, D.C. 20549.  Please call the SEC at 1-800-SEC-0330 for more information on the operation of the public reference room.  Documents may also be available on our web site at http://www.cardinal.com under the heading &#8220;Investors.&#8221;  The information contained on our website is neither incorporated by reference into this registration statement or prospectus or any accompanying prospectus supplement nor intended to be used in connection with any offering hereunder.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">This prospectus is part of a registration statement on Form S-3 that we filed with the SEC, which includes exhibits and other information not included in this prospectus or a prospectus supplement.  The SEC allows us to &#8220;incorporate by reference&#8221; in this prospectus the information we file with it.  This means that we are disclosing important business and financial information to you by referring to other documents filed separately with the SEC that contain the omitted information.  The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update and supersede this information.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We incorporate by reference the following documents filed with the SEC by us and any future filings we make with the SEC after the date of this prospectus under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), until we complete our offering of the securities offered by this prospectus and any accompanying prospectus supplement.  We are not incorporating by reference any information &#8220;furnished&#8221; rather than &#8220;filed&#8221; under Item 2.02 or Item 7.01 of any Current Report on Form 8-K, unless otherwise specified.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">SEC Filings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Period/Date</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Annual Report on Form 10-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Fiscal Year ended June 30, 2016, filed with the SEC on August 12, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Quarterly Reports on Form 10-Q</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Quarter ended September 30, 2016, filed with the SEC on November 2, 2016; and Quarter ended December 31, 2016, filed with the SEC on February 7, 2017</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Current Report on Form 8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed with the SEC on November 7, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Description of common shares contained in Registration Statement on Form 8-A, as updated by description of capital stock contained in Current Reports on Form 8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed with the SEC on August 19, 1994, August 10, 2012 and November 9, 2015</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any statement contained or incorporated by reference in this prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein, or in any subsequently filed document which also is incorporated herein by reference, modifies or supersedes such earlier statement.  Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.  Any statement made in this prospectus concerning the contents of any contract, agreement or other document is only a summary of the actual contract, agreement or other document.  If we have filed or incorporated by reference any contract, agreement or other document as an exhibit to the registration statement, you should read the exhibit for a more complete understanding of the document or matter involved.  Each statement regarding a contract, agreement or other document is qualified by reference to the actual document.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We will furnish without charge to each person (including any beneficial owner) to whom a prospectus is delivered, upon written or oral request, a copy of any or all of the foregoing documents incorporated herein by reference (other than certain exhibits).  Requests for such documents should be made to:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">7000 Cardinal Place</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Dublin, Ohio 43017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(614) 757-5222</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Attention: Investor Relations</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><a name="s26B0028744A0EB642B3AFB26AE432426"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">RISK FACTORS</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Investing in Cardinal Health&#8217;s securities involves significant risks.  Before you invest in Cardinal Health&#8217;s securities, in addition to the other information contained in this prospectus and in the accompanying prospectus supplement, you should carefully consider the risks and uncertainties identified in Cardinal Health&#8217;s reports filed with the SEC that are incorporated by reference into this prospectus and the accompanying prospectus supplement.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><a name="sC4BF69A82F66096016C4FB26AE75666F"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health&#8217;s filings with the SEC, including Cardinal Health&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended June&#160;30, 2016 (the &#8220;2016 Form&#160;10-K&#8221;), any Quarterly Report on Form&#160;10-Q or any Current Report on Form&#160;8-K of Cardinal Health (along with any exhibits and  amendments to such reports), as well as Cardinal Health's news releases or any other written or oral statements made by or on behalf of Cardinal Health, may include, directly or by incorporation by reference, forward-looking statements that reflect Cardinal Health&#8217;s current view (as of the date the forward-looking statement is first made) about future events, prospects, projections or financial performance.  The matters discussed in these forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied in or by such statements.  These risks and uncertainties include:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">competitive pressures in the markets in which we operate, including pricing pressures;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the pricing of generic pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the timing, frequency and profitability of generic pharmaceutical launches;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain the benefits of our generic pharmaceutical sourcing venture with CVS Health Corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">with respect to our distribution agreements with branded pharmaceutical manufacturers, changes in the amount of service fees we receive or, in cases where part of our compensation under these agreements is branded pharmaceutical price appreciation, changes in the frequency or magnitude of such price appreciation; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in the timing or frequency of the introduction of branded pharmaceuticals;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to the frequency or magnitude of branded pharmaceutical price appreciation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">actions of regulatory bodies and other governmental authorities, including the U.S. Drug Enforcement Administration, certain agencies within the U.S. Department of Health and Human Services (including the U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services, the Office of Inspector General and the Office for Civil Rights), the U.S. Nuclear Regulatory Commission, the U.S. Federal Trade Commission, the U.S. Customs and Border Protection, various state boards of pharmacy, state controlled substance agencies, state health departments, state insurance departments, state Medicaid departments or comparable regulatory bodies or governmental authorities or foreign equivalents that, in each case, could delay, limit or suspend product development, manufacturing, distribution, importation or sales or result in warning letters, recalls, seizures, injunctions or monetary sanctions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">difficulties or delays in the development, production, manufacturing, sourcing and marketing of new or existing products and services, including difficulties or delays associated with obtaining requisite regulatory consents or approvals associated with those activities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of healthcare fraud and abuse laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">costs or claims resulting from potential errors or defects in our manufacturing of medical devices or other products or in our compounding, repackaging, information systems or pharmacy management services that may injure persons or damage property or operations, including costs from remediation efforts or recalls and related product liability claims and lawsuits, including class actions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from possible violations of the U.S. Foreign Corrupt Practices Act, Chinese anti-corruption laws and other similar anti-corruption laws in other jurisdictions and U.S. and foreign export control, trade embargo and customs laws;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from our collecting, handling and maintaining patient-identifiable health information and other sensitive personal and financial information, which are subject to federal, state and foreign laws that regulate the use and disclosure of such information;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses being Medicare-certified suppliers or participating in state Medicaid programs, which businesses are subject to accreditation and quality standards and other rules and regulations, including applicable billing, payment and record-keeping requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks arising from certain of our businesses manufacturing pharmaceutical and medical products or repackaging pharmaceuticals that are purchased through federal or state healthcare programs, which businesses are subject to federal and state laws that establish eligibility for reimbursement by such programs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in laws or changes in the interpretation or application of laws or regulations, as well as possible failures to comply with applicable laws or regulations, including as a result of possible misinterpretations or misapplications;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">material reductions in purchases, non-renewal or early termination of contracts, or delinquencies or defaults by key customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">unfavorable changes to the terms of key customer or supplier relationships, or changes in customer mix;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">adverse changes in U.S. or foreign tax laws, including proposals relating to a U.S. "border adjustment tax" or import tariffs, or unfavorable challenges to our tax positions and payments to settle these challenges;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties due to government healthcare reform, including possible modifications to, or repeal of, the Patient Protection and Affordable Care Act;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in manufacturers' pricing, selling, inventory, distribution or supply policies or practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in regulatory policies regarding pharmaceutical manufacturer product pricing practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in hospital buying groups or hospital buying practices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes in distribution or sourcing models for pharmaceutical and medical and surgical products, including an increase in direct and limited distribution;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the risks of counterfeit products in the supply chain;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">changes to the prescription drug reimbursement formula and related reporting requirements for generic pharmaceuticals under Medicaid;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">increasing consolidation in the healthcare industry, which could give the resulting enterprises greater bargaining power and may increase pressure on prices for our products and services or result in the loss of customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">disruption or damage to, or failure of, our information systems, critical facilities, including our national logistics center, or distribution networks;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks to our business and information and controls systems in the event that the Pharmaceutical segment's planned multi-year systems replacement project or other business process improvements, infrastructure modernizations or initiatives to use third-party service providers for key systems and processes are not effectively implemented;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any compromise of our information systems or of those of a third-party with whom we do business, including unauthorized access to or use or disclosure of sensitive information;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the results, costs, effects or timing of any commercial disputes, government contract compliance matters, product liability claims or lawsuits, patent infringement claims, </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">qui tam</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;actions or other legal proceedings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">possible losses relating to product liability claims regarding products for which we cannot obtain product liability insurance or for which such insurance is not adequate to cover our losses;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to maintain adequate intellectual property protections;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the costs, difficulties and uncertainties related to the integration of acquired businesses, including liabilities relating to the operations or activities of such businesses prior to their acquisition, and uncertainties relating to our ability to achieve the anticipated results from acquisitions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks and uncertainties relating to the acquisition of Cordis, including the ability to achieve the expected synergies and positive impact to operating results and the additional risks the Cordis acquisition subjects us to relating to regulatory matters, legal proceedings, tax laws or positions and global operations, including the effects of local economic environments and currency volatility;  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">increased costs for commodities used in the Medical segment including various components, compounds, raw materials or energy such as oil-based resins, cotton, latex and other commodities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">shortages in commodities, components, compounds, raw materials or energy used by our businesses, including supply disruptions of radioisotopes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the loss of, or default by, one or more key suppliers for which alternative suppliers may not be readily available;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">bankruptcy, insolvency or other credit failure of a customer or supplier that owes us a substantial amount;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with global operations, including the effect of local economic environments, inflation, recession, currency volatility and global competition, in addition to risks associated with compliance with U.S. and international laws relating to global operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">risks associated with volatility and disruption to the global capital and credit markets, which may adversely affect our ability to access credit, our cost of credit and the financial soundness of our customers and suppliers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our ability to introduce and market new products and our ability to keep pace with advances in technology;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the costs, effects, timing or success of restructuring programs or plans;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">significant charges to earnings if goodwill or intangible assets become impaired; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">uncertainties relating to general political, business, industry, regulatory and market conditions; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">other factors described in the &#8220;Risk Factors&#8221; section of the 2016 Form 10-K.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; and similar expressions generally identify &#8220;forward-looking statements,&#8221; which speak only as of the date the statements were made, and also include statements reflecting future results or guidance, statements of outlook and expense accruals.  We undertake no obligation to update or revise any forward-looking statements, except to the extent required by applicable law.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div><a name="sE88299F372D064AEE7F2FB26AE9E823E"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">THE COMPANY</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. is an Ohio corporation formed in 1979.  We are a globally integrated healthcare services and products company providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physicians' offices.  We provide clinically proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency.  We connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">For additional information concerning our business and our financial results and condition, please refer to the documents incorporated by reference in this prospectus.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The mailing address of our executive offices is 7000 Cardinal Place, Dublin, Ohio 43017, and our telephone number is (614)&#160;757-5000.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div><a name="sA298B3981B30DB69E95EFB26AEC9059C"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">USE OF PROCEEDS</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Except as we may describe otherwise in a prospectus supplement, we will use the net proceeds from the sale of any offered securities for general corporate purposes, which may include working capital, capital expenditures, repayment or refinancing of indebtedness, acquisitions, repurchases of Cardinal Health&#8217;s common shares, dividends or investments.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><a name="sE3F2A867244F1FD0157EFB26AEEA9A24"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">RATIO OF EARNINGS TO FIXED CHARGES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Our ratio of earnings to fixed charges for each of the fiscal years ended June&#160;30, 2012 through 2016 and for the six months ended December&#160;31, 2016 was as follows:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.60317460317461%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:33%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:17%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Fiscal Year Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Six Months Ended December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Ratio of Earnings to Fixed Charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">7.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">13.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">13.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">12.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">10.7</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The ratio of earnings to fixed charges is computed by dividing fixed charges into earnings from continuing operations before income taxes plus fixed charges and capitalized interest.  Fixed charges include interest expense, amortization of debt offering costs and the portion of rent expense that is deemed to be representative of the interest factor.  Interest expense recorded on tax exposures has been recorded in income tax expense and has therefore been excluded from the calculation. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><a name="s90E4813633295E86061BFB26AF1C66EB"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">DESCRIPTION OF CAPITAL STOCK</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following is a summary of Cardinal Health&#8217;s capital stock.  The following summary of the terms of Cardinal Health&#8217;s capital stock is not meant to be complete and is qualified by reference to Cardinal Health&#8217;s Amended and Restated Articles of Incorporation, as amended (the &#8220;Articles&#8221;), and Cardinal Health&#8217;s Restated Code of Regulations (the &#8220;Regulations&#8221;), which are the documents that establish these rights.  Copies of the Articles and Regulations are incorporated by reference in the registration statement of which this prospectus is a part.  See &#8220;Where You Can Find More Information and Incorporation of Certain Documents by Reference&#8221; on page 2 of this prospectus for information on how to obtain copies of documents incorporated by reference in the registration statement of which this prospectus is a part.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The Articles authorize Cardinal Health to issue up to 750 million common shares.  On January 31, 2017, approximately 315 million common shares were issued and outstanding and approximately 11 million were held in treasury.  The Articles also authorize Cardinal Health to issue up to 5 million Class B common shares, none of which are outstanding or reserved for issuance, and 500,000 non-voting preferred shares, none of which are outstanding or reserved for issuance.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">From time to time, Cardinal Health may issue additional authorized but unissued common shares for share dividends, stock splits, employee benefit and compensation programs, financing and acquisition transactions, and other general purposes.  Those common shares will be available for issuance without action by Cardinal Health&#8217;s shareholders, unless action by the Cardinal Health shareholders is required by applicable law or the rules of the New York Stock Exchange or any other stock exchange on which common shares may be listed in the future.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Common Shares</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All of the outstanding common shares are fully paid and nonassessable.  Holders of common shares do not have preemptive rights and have no right to convert their common shares into any other security.  All common shares are entitled to participate equally and ratably in dividends, when and as declared by Cardinal Health&#8217;s board of directors.  In the event of the liquidation of Cardinal Health, holders of common shares are entitled to share ratably in assets remaining after payment of all liabilities, subject to prior distribution rights of any preferred shares then outstanding.  Holders of common shares are entitled to one vote per share upon all matters on which shareholders are entitled to vote.  Holders of Class B common shares (if any are issued in the future) are entitled to one-fifth of one vote per share upon all matters on which shareholders are entitled to vote.  Except as otherwise expressly provided by law, the Articles or the Regulations, all matters on which shareholders are entitled to vote will be decided by the majority of votes cast without regard to abstentions.  Under certain circumstances, holders of Class B common shares have a right to a separate class vote.  Holders of common shares do not have any rights to cumulate votes in the election of directors.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Preferred Shares</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">No shares of non-voting preferred shares are currently outstanding.  Under the Articles, Cardinal Health&#8217;s board of directors, without further action by its shareholders, is authorized to issue up to 500,000 non-voting preferred shares, without par value, in one or more series and to fix the designations, preferences, limitations and relative or other rights thereof, including the designation and authorized number of shares constituting each series, dividend rights, liquidation price, redemption rights, sinking fund requirements, conversion rights and restrictions on the issuance of such shares.  The issuance of preferred shares could adversely affect the holders of common shares.  The issuance of preferred shares could also have the effect, under certain circumstances, of delaying, deferring or preventing a change of control of Cardinal Health.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Board of Directors</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health&#8217;s board of directors currently consists of eleven members.  The Regulations provide that the number of directors is fixed from time to time by the board of directors, but in no case may the number of directors be decreased to fewer than nine nor increased to more than sixteen.  The board of directors may fill any vacancy, including a vacancy created by an increase in the number of directors.  Each director serves until the next annual meeting of shareholders and until his or her successor is duly elected and qualified or until his or her earlier resignation, removal from office or death.  In uncontested elections of directors, as defined in the Articles, directors are elected by a majority of the votes cast; director elections other than uncontested elections are governed by a plurality voting standard.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Anti-takeover Protections</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following summarizes Chapter 1704 of the Ohio Revised Code which may have the effect of prohibiting, raising the costs of, or otherwise impeding, a change of control of Cardinal Health, whether by merger, consolidation or sale of assets or stock (by tender offer or otherwise), or by other methods.  Chapter 1704 provides generally that any person who has beneficial ownership of 10% or more of a corporation&#8217;s voting stock (thereby being an &#8220;interested shareholder&#8221;) may not engage in a wide range of &#8220;business combinations&#8221; with the corporation for a period of three years following the date the person became an interested shareholder, unless the directors of the corporation have approved the transaction or the interested shareholder&#8217;s acquisition of shares of the corporation, in either case, prior to the date the interested shareholder became an interested shareholder of the corporation.  After the three-year period, business combinations between the corporation and the interested shareholder are prohibited unless certain fair price provisions are complied with or the shareholders of the corporation approve the transaction by the affirmative vote of two-thirds of the voting power of the corporation, including at least a majority of the disinterested </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">shareholders.  These restrictions on interested shareholders do not apply under certain circumstances, including when a person becomes an &#8220;interested shareholder&#8221; only because a corporation has repurchased some of its voting stock.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Exclusive Forum Provision</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The Regulations provide that, unless Cardinal Health consents in writing to the selection of an alternate forum, a state court located in Franklin County, Ohio (or if no state court in Franklin County, Ohio has jurisdiction, then the federal court for Franklin County, Ohio) will be the exclusive forum for derivative suits and certain other actions, including any action asserting a claim against Cardinal Health or any director, officer or other employee arising under Ohio corporation law, the Articles or the Regulations.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Transfer Agent and Registrar</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The transfer agent and registrar for the common shares is Computershare Trust&#160;Company, N.A., Canton, Massachusetts.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div><a name="sB471F5A0D00C6490ACA7FB26AF3F9FBD"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">DESCRIPTION OF DEBT SECURITIES</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following description summarizes the general terms and provisions of the debt securities that Cardinal Health may offer pursuant to this prospectus that are common to all series.  The specific terms relating to any series of the debt securities that Cardinal Health may offer will be described in a prospectus supplement, which you should read.  Because the terms of specific series of debt securities offered may differ from the general information that Cardinal Health has provided below, you should rely on information in the applicable prospectus supplement that contradicts any information below.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As required by federal law for all bonds and notes of companies that are publicly offered, the debt securities will be governed by a document called an &#8220;indenture.&#8221; An indenture is a contract between a financial institution, acting on your behalf as trustee of the debt securities offered, and Cardinal Health.  The debt securities will be issued pursuant to an indenture, dated as of June&#160;2, 2008, between Cardinal Health and The Bank of New York Mellon Trust&#160;Company, N.A. (formerly The Bank of New York Trust&#160;Company, N.A.), as trustee, unless otherwise indicated in the applicable prospectus supplement.  When Cardinal Health refers to the &#8220;indenture&#8221; in this prospectus, Cardinal Health is referring to the indenture under which your debt securities are issued, as may be supplemented by any supplemental indenture applicable to your debt securities.  The trustee has two main roles.  First, subject to some limitations on the extent to which the trustee can act on your behalf, the trustee can enforce your rights against Cardinal Health if Cardinal Health defaults on its obligations under the indenture.  Second, the trustee performs certain administrative duties for Cardinal Health with respect to the debt securities.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Unless otherwise provided in any applicable prospectus supplement, the following section is a summary of the principal terms and provisions that will be included in the indenture.  This summary is not complete and is subject to, and qualified in its entirety by reference to, the terms and provisions of the indenture, which will be in the form filed as an exhibit to or incorporated by reference in the registration statement of which this prospectus is a part.  If this summary refers to particular provisions in the indenture, such provisions, including the definition of terms, are incorporated by reference in this prospectus as part of this summary.  Cardinal Health urges you to read the applicable indenture and any supplement thereto because these documents, and not this section, define your rights as a holder of debt securities.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In this section, &#8220;Cardinal Health&#8221; refers to Cardinal Health, Inc., excluding its subsidiaries, unless otherwise expressly stated or the context otherwise requires.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">General</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The indenture does not limit the amount of debt securities or any other debt Cardinal Health may incur.  The indenture provides that the debt securities may be issued from time to time in one or more series.  The debt securities may have the same or various maturities.  The debt securities may be issued at par, at a premium or with original issue discount.  Cardinal Health may also reopen a previous issue of securities and issue additional securities of the series.  The debt securities will be unsecured obligations of Cardinal Health.  Senior debt securities will rank equally in right of payment with all of Cardinal Health&#8217;s existing and future unsecured and unsubordinated indebtedness.  Subordinated debt securities will be unsecured and subordinated in right of payment to the prior payment in full of all of Cardinal Health&#8217;s unsecured and senior indebtedness.  Unless otherwise specified in a prospectus supplement, a default in Cardinal Health&#8217;s obligations with respect to any other indebtedness will not constitute a default or an event of default with respect to the debt securities.  The indenture does not contain any covenants or provisions that afford holders of debt securities protection in the event of a highly leveraged transaction.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health conducts nearly all of its operations through subsidiaries and it expects that it will continue to do so.  As a result, the right of Cardinal Health to participate as a shareholder in any distribution of assets of any subsidiary upon its liquidation or reorganization or otherwise and the ability of holders of the debt securities to benefit as creditors of Cardinal Health from any distribution are subject to the prior claims of creditors of the subsidiary.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The prospectus supplement relating to any series of debt securities will, among other things, describe the following terms, where applicable:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the title of the debt securities and whether the debt securities will be senior or subordinated;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the total principal amount of the debt securities and any limit upon the aggregate principal amount of the debt securities of the series;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the date or dates on which the principal of the debt securities will be payable, or the method by which such date or dates will be determined;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the rate or rates at which the debt securities will bear interest, if any, or the method by which such rate will be determined, the date or dates from which such interest will accrue, the interest payment dates on which such interest will be payable and the record dates for the determination of holders of debt securities to whom interest is payable, or the method by which such date or dates will be determined, and the basis upon which interest will be calculated if other than on the basis of a 360-day year of twelve 30-day months;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if in addition to or other than The City of New York, the place for payment, registration, transfer, exchange or conversion of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any optional redemption provisions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any sinking fund or analogous provisions that would obligate us to redeem, repurchase or repay the debt securities;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if other than denominations of $1,000 and any integral multiple thereof in the case of debt securities in registered form and denominations of $5,000 in the case of debt securities in bearer form, the denominations in which the debt securities will be issuable;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if other than the principal amount thereof, the portion of the principal amount of debt securities which will be payable upon declaration of acceleration of the maturity thereof or provable in bankruptcy or the method by which such portion will be determined;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if other than U.S. dollars, the currency or currencies in which the debt securities will be denominated or payable;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">whether the amount of payments of principal of or interest, if any, on the debt securities may be determined with reference to an index, formula or other method (which may be based on one or more currencies, commodities, equity indices or other indices), and how such amounts will be determined;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if the provisions of the indenture described under &#8220;Defeasance&#8221; are not applicable to the debt securities and any provisions in modification of such provisions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any provisions granting special rights to the holders of the debt securities upon the occurrence of specified events;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">whether the debt securities are to be issuable in registered form, in bearer form or both, any restrictions applicable to the offer, sale or delivery of debt securities in bearer form, whether the debt securities are to be issuable initially in temporary global form or issuable in permanent global form, and, if so, whether beneficial owners may exchange such interests for debt securities of like tenor of any authorized form and denomination and the circumstances under which any such exchanges may occur, and whether debt securities in registered form may be exchanged for debt securities in bearer form and the circumstances under which any such exchanges may occur;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any modifications to the events of default or covenants of Cardinal Health with respect to the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if the debt securities are to be issuable in definitive form only upon receipt of certain certificates or other documents or satisfaction of other conditions, the form and/or terms of such certificates, documents or conditions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if the debt securities are to be issued upon the exercise of warrants, the time, manner and place for such debt securities to be authenticated and delivered;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if the debt securities are to be convertible into or exchangeable for any other securities, and the applicable terms and conditions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">whether the debt securities are subject to subordination and the terms of any such subordination;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any other material terms of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any trustees, authenticating or paying agents, transfer agents or registrars or any other agents with respect to the debt securities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">whether the debt securities or any portion thereof will be issuable as global securities and any depositary for such global securities.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Unless otherwise specified in a prospectus supplement, principal and premium, if any, will be payable, and the debt securities will be transferable and exchangeable without service charge, at the office of the trustee under the indenture.  Interest on any series of the debt securities will be payable on the interest payment dates to the persons in whose names the debt securities are registered at the close of business on the related record dates, and, unless other arrangements are made, will be paid by checks mailed to such persons.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The debt securities may be issued as discounted debt securities (bearing no interest or interest at a rate which at the time of issuance is below market rates) and sold at a discount which may be substantially below their stated principal amount (&#8220;Original Issue Discount Securities&#8221;).  The applicable prospectus supplement may describe the federal income tax consequences and other special considerations applicable to any Original Issue Discount Securities.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Definitions</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The definitions set forth below are a description of the terms that are defined in the indenture and used in this prospectus.  The complete definitions are set forth in the indenture.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Attributable Debt&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means, in connection with a sale and lease-back transaction, the lesser of:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the fair value of the assets subject to the transaction; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the aggregate of present values (discounted at a rate per annum equal to the weighted average Yield to Maturity of the debt securities of all series then outstanding and compounded semiannually) of Cardinal Health&#8217;s or any Consolidated Subsidiary's obligations for net rental payments during the remaining term of all leases.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Consolidated Subsidiary&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means any Subsidiary substantially all the property of which is located, and substantially all the operations of which are conducted, in the United States of America whose financial statements are consolidated with those of Cardinal Health in accordance with generally accepted accounting principles.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Exempted Debt&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means the sum of the following as of the date of determination:</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our indebtedness incurred after the date of the indenture and secured by liens not permitted by the limitation on liens provisions of the indenture; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">our Attributable Debt in respect of every sale and lease-back transaction entered into after the date of the indenture, other than leases permitted by the limitation on sale and lease-back provisions of the indenture.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Financing Subsidiary&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means any Subsidiary, including its Subsidiaries, engaged in one or more of the following activities:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the business of making loans or advances, extending credit or providing financial accommodations (including leasing new or used products) to others;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the business of purchasing notes, accounts receivable (whether or not payable in installments), conditional sale contracts or other obligations of others originating in sales at wholesale or retail; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any other business as may be reasonably incidental to those described herein, including the ownership and use of property in connection therewith.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8220;</font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Funded Indebtedness</font><font style="font-family:Arial Narrow;font-size:10pt;">&#8221; means all Indebtedness having a maturity of more than 12&#160;months from the date as of which the amount of Indebtedness is to be determined or having a maturity of less than 12&#160;months but by its terms being renewable or extendible beyond 12&#160;months from such date at the option of the borrower.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Indebtedness&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means all items classified as indebtedness on our most recently available balance sheet in accordance with generally accepted accounting principles.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Net Worth&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means, as of any date of determination, the total shareholder&#8217;s equity of Cardinal Health and its Subsidiaries calculated on a consolidated basis in accordance with generally accepted accounting principles.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Original Issue Discount Security&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means any debt security that provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration of the maturity thereof following an event of default.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Rate Hedging Obligations&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means any and all obligations of anyone arising under:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any and all agreements, devices or arrangements designed to protect at least one of the parties thereto from the fluctuations of interest rates, exchange rates or forward rates applicable to such party&#8217;s assets, liabilities or exchange transactions; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any and all cancellations, buybacks, reversals, terminations or assignments of the same.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Restricted Subsidiary&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means a &#8220;significant subsidiary&#8221; as defined in Article&#160;1, Rule&#160;1-02 of Regulation&#160;S-X, promulgated under the Securities Act.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Senior Funded Indebtedness&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means any of Cardinal Health&#8217;s Funded Indebtedness that is not subordinated in right of payment to any of Cardinal Health&#8217;s other Indebtedness.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Subsidiary&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means any corporation, partnership, limited liability company, business trust, trust or other legal entity of which at least a majority of the outstanding stock or other ownership interests having voting power to elect a majority of the board of directors, managers or trustees of that corporation, partnership, limited liability company, business trust, trust or other legal entity (irrespective of whether or not at the time stock or other ownership interests of any other class or classes of such corporation, partnership, limited liability company, business trust, trust or other legal entity shall have or might have voting power by reason of the happening of any contingency) is at the time owned by Cardinal Health or by Cardinal Health and one or more Subsidiaries or by one or more Subsidiaries.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Yield to Maturity&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;means the yield to maturity on a series of debt securities, calculated at the time of issuance of such series, or, if applicable, at the most recent redetermination of interest on such series, and calculated in accordance with accepted financial practice.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Certain Covenants</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following is a summary of the material covenants contained in the indenture.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Limitations on Liens</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">So long as any of the debt securities remain outstanding, Cardinal Health will not, and it will not permit any Consolidated Subsidiary to, create or assume any Indebtedness for borrowed money that is secured by a mortgage, pledge, security interest or lien (the &#8220;liens&#8221;) of or upon any assets of Cardinal Health or any Consolidated Subsidiary, whether now owned or hereafter acquired, without equally and ratably securing the debt securities by a lien ranking ratably with and equal to such secured Indebtedness.  The foregoing restriction does not apply to:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens existing on the date of the indenture;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens on assets of any corporation existing at the time it becomes a Consolidated Subsidiary;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens on assets existing at the time Cardinal Health or a Consolidated Subsidiary acquires them, or to secure the payment of the purchase price for them, or to secure Indebtedness incurred or guaranteed by Cardinal Health or a Consolidated Subsidiary for the purpose of financing the purchase price of assets, or, in the case of real property, construction or improvements thereon, which Indebtedness is incurred or guaranteed prior to, at the time of, or within 360&#160;days after the acquisition (or in the case of real property, completion of construction or improvements or commencement of full operation of such asset, whichever is later) provided that the lien shall not apply to any assets theretofore owned by Cardinal Health or a Consolidated Subsidiary other than, in the case of any such construction or improvements, any real property on which the construction or improvement is located;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens securing Indebtedness owing by any Consolidated Subsidiary to Cardinal Health or another wholly owned domestic Subsidiary;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(e)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens on any assets of a corporation existing at the time the corporation is merged into or consolidated with Cardinal Health or a Subsidiary or at the time of a purchase, lease or other acquisition of the assets of a corporation or firm as an entirety or substantially as an entirety by Cardinal Health or a Subsidiary;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(f)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens on any assets of Cardinal Health or a Consolidated Subsidiary in favor of the United States of America or any State or political subdivision thereof, or in favor of any other country, or political subdivision thereof, to secure certain payments pursuant to any contract or statute or to secure any Indebtedness incurred or guaranteed for the purpose of financing all or any part of the purchase price (or, in the case of real property, the cost of construction) of the assets subject to such liens (including, but not limited to, liens incurred in connection with pollution control, industrial revenue or similar financings);</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(g)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any extension, renewal or replacement (or successive extensions, renewals or replacements) in whole or in part, of any lien referred to in the foregoing clauses&#160;(a) to (f), inclusive;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(h)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">certain statutory liens or other similar liens arising in the ordinary course of business or certain liens arising out of governmental contracts;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">certain pledges, deposits or liens made or arising under workers&#8217; compensation or similar legislation or in certain other circumstances;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(j)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens created by or resulting from certain legal proceedings, including certain liens arising out of judgments or awards;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(k)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens for certain taxes or assessments, landlord&#8217;s liens and liens and charges incidental to the conduct of our business, or our ownership of our assets which were not incurred in connection with the borrowing of money and which do not, in Cardinal Health&#8217;s opinion, materially impair our use of such assets in our operations or the value of the assets for its purposes;&#160;or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(l)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">liens on any assets of a Financing Subsidiary.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Notwithstanding the foregoing restrictions, we may create or assume any Indebtedness which is secured by a lien without securing the debt securities, provided that at the time of such creation or assumption, and immediately after giving effect thereto, the Exempted Debt then outstanding at such time does not exceed 20% of Net Worth.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Limitations on Subsidiary Indebtedness</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health will not permit any Restricted Subsidiary directly or indirectly to incur any Indebtedness for borrowed money, except that the foregoing limitations will not apply to the incurrence of:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness outstanding on the date of the indenture;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness of a Restricted Subsidiary that represents its assumption of Indebtedness of another Subsidiary, and Indebtedness owed by any Restricted Subsidiary to Cardinal Health or to another Subsidiary; provided that such Indebtedness will be held at all times by either Cardinal Health or a Subsidiary; and provided further that upon the transfer or disposition of such Indebtedness to someone other than Cardinal Health or another Subsidiary, the incurrence of such Indebtedness will be deemed to be an incurrence that is not permitted;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness arising from (i)&#160;the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business or (ii)&#160;the honoring by a bank or other financial institution of a check, draft or similar instrument inadvertently (except in the case of daylight overdrafts) drawn against insufficient funds in the ordinary course of business; provided that such overdraft is extinguished within five business days of incurrence;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness arising from guarantees of loans and advances by third parties to employees and officers of a Restricted Subsidiary in the ordinary course of business for bona fide business purposes; provided that the aggregate amount of such guarantees by all Restricted Subsidiaries does not exceed $1,000,000;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(e)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness incurred by a foreign Restricted Subsidiary in the ordinary course of business;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(f)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness of any corporation existing at the time such corporation becomes a Restricted Subsidiary or is merged into a Restricted Subsidiary or at the time of a purchase, lease or other acquisition by a Restricted Subsidiary of all or substantially all of the assets of such corporation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(g)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness of a Restricted Subsidiary arising from agreements or guarantees providing for or creating any obligations of Cardinal Health or any of its Subsidiaries incurred in connection with the disposition of any business, property or Subsidiary, excluding guarantees or similar credit support by a Restricted Subsidiary of indebtedness incurred by the acquirer of such business, property or Subsidiary for the purpose of financing such acquisition;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(h)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness of a Restricted Subsidiary with respect to bonds, bankers&#8217; acceptances or letters of credit provided by such Subsidiary in the ordinary course of business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness secured by a lien permitted by the provisions regarding limitations on liens or arising in respect of a sale and lease-back transaction permitted by the provisions regarding such transactions, or any Indebtedness incurred to finance the purchase price or cost of construction of improvements with respect to certain property or assets acquired after the date of the indenture;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(j)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness that is issued, assumed or guaranteed in connection with compliance by a Restricted Subsidiary with the requirements of any program, applicable to such Restricted Subsidiary, adopted by any governmental authority that provides for financial or tax benefits which are not available directly to Cardinal Health;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(k)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness arising from Rate Hedging Obligations incurred to limit risks of currency or interest rate fluctuations to which a Subsidiary is otherwise subject by virtue of the operations of its business, and not for speculative purposes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(l)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness incurred by any Financing Subsidiary;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(m)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indebtedness incurred in connection with refinancing of any Indebtedness described in clauses (a), (b), (f), (g), and (i)&#160;above (the &#8220;Refinancing Indebtedness&#8221;), provided that:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the principal amount of the Refinancing Indebtedness does not exceed the principal amount of the Indebtedness refinanced (plus the premiums paid and expenses incurred in connection therewith),</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the Refinancing Indebtedness has a weighted average life to maturity equal to or greater than the weighted average life to maturity of the Indebtedness being refinanced,&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the Refinancing Indebtedness ranks no more senior, and is at least as subordinated in right of payment, as the Indebtedness being refinanced.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Notwithstanding the foregoing restrictions, Restricted Subsidiaries may incur any Indebtedness for borrowed money that would otherwise be subject to the foregoing restrictions in an aggregate principal amount which, together with the aggregate principal amount of other Indebtedness (not including the Indebtedness permitted above), does not, at the time such Indebtedness is incurred, exceed 20% of Net Worth.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Limitation on Sale and Lease-Back Transactions</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Sale and lease-back transactions (except those transactions involving leases for less than three years) by Cardinal Health or any Consolidated Subsidiary of any assets are prohibited unless:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health or the Consolidated Subsidiary would be entitled to incur Indebtedness secured by a lien on the assets to be leased in an amount at least equal to the Attributable Debt with respect to such transaction without equally and ratably securing the notes; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the proceeds of the sale of the assets to be leased are at least equal to their fair value as determined by Cardinal Health&#8217;s board of directors and the proceeds are applied to the purchase or acquisition (or, in the case of real property, the construction) of assets or to the retirement of Senior Funded Indebtedness.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The foregoing limitation will not apply if at the time Cardinal Health or any Consolidated Subsidiary enters into such sale and lease-back transaction, immediately after giving effect thereto, Exempted Debt does not exceed 20% of Net Worth.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Merger, Consolidation, Sale, Lease or Conveyance</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health will not merge or consolidate with any other corporation and will not sell, lease or convey all or substantially all its assets to any person, unless:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health will be the continuing corporation; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(a) the successor corporation or person that acquires all or substantially all of Cardinal Health&#8217;s assets is a corporation, partnership, limited liability company, business trust, trust or other legal entity organized under the laws of the United States or a State thereof or the District of Columbia; and (b) the successor corporation or person expressly assumes all of Cardinal Health&#8217;s obligations under </font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-left:48px;padding-bottom:8px;text-align:justify;"><font style="font-family:Arial Narrow;font-size:10pt;">the indenture and the debt securities; and (c) immediately after such merger, consolidation, sale, lease or conveyance, the successor corporation or person is not in default in the performance of the covenants and conditions of the indenture to be performed or observed by Cardinal Health.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;text-indent:-24px;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Modification of the Indenture</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health and the trustee cannot modify the indenture or any supplemental indenture or the rights of the holders of the debt securities without the consent of holders of at least a majority of the principal amount of the outstanding debt securities of each series affected by the modification.  Cardinal Health and the trustee cannot modify the indenture without the consent of the holder of each outstanding debt security of such series affected by such modification to:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">extend the final maturity of any of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reduce the principal amount;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reduce the rate or extend the time of payment of interest;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reduce any amount payable on redemption;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reduce the amount of the principal of an Original Issue Discount Security that would be due and payable upon an acceleration of the maturity;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">reduce the amount of an Original Issue Discount Security provable in bankruptcy;&#160;or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">impair or affect the right of any holder of the debt securities to institute suit for payment.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In addition, the consent of all holders of the debt securities is required to reduce the percentage of consent required to effect any modification.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health and the trustee may modify the indenture or enter into supplemental indentures without the consent of the holders of the debt securities, in certain cases, including:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to convey, transfer, assign, mortgage or pledge to the trustee as security for the debt securities any property or assets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to evidence the succession of another corporation, partnership, limited liability company, business trust, trust or other legal entity to Cardinal Health and the assumption by the successor corporation, partnership, limited liability company, business trust, trust or other legal entity of the covenants, agreements and obligations of Cardinal Health;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to add to Cardinal Health&#8217;s covenants any further covenants, restrictions, conditions or provisions considered to be for the protection of the holders;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to cure any ambiguity or to correct or supplement any provision contained in the indenture which may be defective or inconsistent with any other provision contained in the indenture or to make such other provisions in regard to matters or questions arising under the indenture that will not adversely affect the interests of the holders of the debt securities in any material respect;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to establish the form or terms of the debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to evidence or provide for the acceptance of appointment by a successor trustee and to add to or change any of the provisions of the indenture that may be necessary to provide for or facilitate the administration of the trusts created thereunder by more than one trustee;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to add to or change any of the provisions of the indenture to such extent as may be necessary to permit or facilitate the issuance of debt securities in bearer form, registrable or not registrable as to principal, and with or without interest coupons, or to permit or facilitate the issuance of debt securities in uncertificated form;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to supplement any of the provisions of the indenture to such extent as is necessary to permit or facilitate the defeasance and discharge of any series of debt securities, provided that any such action will not adversely affect the interests of any holder of an outstanding debt security of such series or any other outstanding debt security in any material respect;&#160;or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">to amend or supplement any provision contained in the indenture or in any supplemental indenture, provided that no such amendment or supplement will materially adversely affect the interests of the holders of any debt securities then outstanding.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Events of Default</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The following constitute events of default under the indenture with respect to each series of debt securities:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">failure to pay principal of and premium, if any, on any debt securities of such series when due;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">failure to pay interest on any debt securities of such series when due for 30&#160;days;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">failure to perform any other covenant or agreement of Cardinal Health in respect of the debt securities of such series for 90&#160;days after written notice to Cardinal Health specifying that such notice is a &#8220;notice of default&#8221; under the indenture;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">failure to pay any sinking fund installment when due on any debt securities of such series;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">certain events of bankruptcy or insolvency of Cardinal Health;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">any other event of default provided in the supplemental indenture or resolutions of Cardinal Health&#8217;s board of directors under which such debt securities are issued or in the form of debt security for such series.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If an event of default occurs and is continuing due to the default in the performance or breach of clauses (1), (2), (3), (4)&#160;or (6)&#160;above with respect to any series of debt securities but not with respect to all outstanding debt securities issued, either the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of each affected series (each series voting as a separate class) may declare the principal amount and interest accrued of all such affected series of the debt securities to be due and payable immediately.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If an event of default occurs and is continuing due to a default in the performance of any of the covenants or agreements in the indenture applicable to all outstanding debt securities issued and then outstanding or due to certain events of bankruptcy or insolvency of Cardinal Health, either the trustee or the holders of not less than 25% in principal amount of all debt securities issued (treated as one class) may declare the principal amount and interest accrued of all such debt securities to be due and payable immediately.  However, such declarations may be annulled and any defaults may be waived upon the occurrence of certain conditions, including deposit by Cardinal Health with the trustee of a sum sufficient to pay all matured installments of interest and principal and certain expenses of the trustee.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A default by Cardinal Health with respect to any Indebtedness other than the debt securities will not constitute an event of default with respect to the debt securities.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The trustee may withhold notice to the holders of any series of debt securities of any default (except in payment of principal of, or interest on, or in the payment of any sinking or purchase fund installment) if the trustee considers it in the interest of such holders to do so.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Subject to the provisions for indemnity and certain other limitations contained in the indenture, the holders of a majority in principal amount of each series of the debt securities then outstanding will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">No holder of the debt securities of a series may institute any action against Cardinal Health under the indenture unless:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">that holder gives to the trustee advance written notice of default and its continuance;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the holders of not less than 25% in aggregate principal amount of the debt securities of such series then outstanding affected by that event of default request the trustee to institute such action;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">that holder or holders has offered the trustee reasonable indemnity as it may require;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the trustee has not instituted such action within 60&#160;days of such notice, request and offer of indemnity;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the trustee has not, during such 60-day period, received direction inconsistent with such written request by the holders of a majority in aggregate principal amount of the debt securities of each affected series then outstanding.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">At any time prior to the evidencing to the trustee of the taking of any action by the holders of the percentage in aggregate principal amount of the debt securities of any or all series specified in the indenture in connection with such action, any holder of a debt security may, by filing written notice with the trustee, revoke such action concerning such security.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health is required to deliver to the trustee each year a certificate as to whether or not, to the knowledge of the officers signing such certificate, Cardinal Health is in compliance with the conditions and covenants under the indenture.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Satisfaction and Discharge</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The indenture provides that Cardinal Health will be discharged from all obligations under the indenture and the indenture will cease to be of further effect when:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health has paid all sums payable by it under the indenture;&#160;or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health has delivered to the trustee for cancellation all authenticated debt securities;&#160;or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">all the debt securities not delivered to the trustee for cancellation have become due and payable or are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the trustee, and Cardinal Health has irrevocably deposited with the trustee as trust funds an amount in cash sufficient to pay the principal and interest at maturity or upon redemption of such debt securities not previously delivered to the trustee for cancellation and paid all other sums payable with respect to such debt securities;&#160;and</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">the trustee, on demand of and at the expense of Cardinal Health and upon compliance by Cardinal Health with certain conditions, will execute proper instruments acknowledging satisfaction and discharge of the indenture.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Defeasance</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The term &#8220;defeasance,&#8221; as used in the indenture, means discharge from some or all of our obligations under the indenture.  If we deposit with the trustee sufficient cash or government securities to pay the principal, any premium, interest and any other sums due at maturity or on a redemption date of the securities of a particular series, then at our option:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">we will be discharged from our obligations with respect to the securities of such series;&#160;or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">we will no longer be under any obligation to comply with certain restrictive covenants under the indenture, and certain events of default will no longer apply to us.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If this happens, the holders of the securities of the affected series will not be entitled to the benefits of the indenture except for registration of transfer and exchange of debt securities and replacement of lost, stolen or mutilated securities.  Such holders may look only to such deposited funds or obligations for payment.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To exercise such option, we are required to deliver to the Trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the holders of the securities to recognize income, gain or loss for federal income tax purposes. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Form and Denomination of Debt Securities</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Denomination of Debt Securities</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Unless otherwise indicated in the applicable prospectus supplement, the debt securities will be denominated in U.S.&#160;dollars, in minimum denominations of $1,000 and integral multiples thereof.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Registered Form</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health may issue the debt securities in registered form, in which case Cardinal Health may issue them either in book-entry form only or in &#8220;certificated&#8221; form.  Cardinal Health will issue registered debt securities in book-entry form only, unless it specifies otherwise in the applicable prospectus supplement.  Debt securities issued in book-entry form will be represented by global securities.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Holders of Registered Debt Securities</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Book-Entry Holders</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health will issue registered debt securities in book-entry form only, unless Cardinal Health specifies otherwise in the applicable prospectus supplement.  Debt securities held in book-entry form will be represented by one or more global securities registered in the name of a depositary or its nominee.  The depositary or its nominee will hold such global securities on behalf of financial institutions that participate in such depositary&#8217;s book-entry system.  These participating financial institutions, in turn, hold beneficial interests in the global securities either on their own behalf or on behalf of their customers.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Under the indenture, only the person in whose name a debt security is registered is recognized as the holder of that debt security.  Consequently, for debt securities issued in global form, Cardinal Health will recognize only the depositary or its nominee as the holder of the debt securities, and Cardinal Health will make all payments on the debt securities to the depositary or its nominee.  The depositary will then pass along the payments that it receives to its participants, which in turn will pass the payments along to their customers who are the beneficial owners of the debt securities.  The depositary and its participants do so under agreements they have made with one another or with their customers or by law; they are not obligated to do so under the terms of the debt securities or the terms of the indenture.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As a result, investors will not own debt securities directly.  Instead, they will own beneficial interests in a global security, through a bank, broker or other financial institution that participates in the depositary&#8217;s book-entry system, or that holds an interest through a participant in the depositary&#8217;s book-entry system.  As long as the debt securities are issued in global form, investors will be indirect holders, and not holders, of the debt securities.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Street Name Holders</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In the event that Cardinal Health issues debt securities in certificated form, or in the event that a global security is terminated, investors may choose to hold their debt securities either in their own names or in &#8220;street name.&#8221;  Debt securities held in street name are registered in the name of a bank, broker or other financial institution chosen by the investor, and the investor would hold a beneficial interest in those debt securities through the account that he or she maintains at such bank, broker or other financial institution.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">For debt securities held in street name, Cardinal Health will recognize only the intermediary banks, brokers and other financial institutions in whose names the debt securities are registered as the holders of those debt securities, and Cardinal Health will make all payments on those debt securities to them.  These institutions will pass along the payments that they receive from Cardinal Health to their customers who are the beneficial owners pursuant to agreements that they have entered into with such customers or by law; they are not obligated to do so under the terms of the debt securities or the terms of the indenture.  Investors who hold debt securities in street name will be indirect holders, and not holders, of the debt securities.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Registered Holders</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health&#8217;s obligations, as well as the obligations of the trustee and those of any third parties employed by the trustee or Cardinal Health, run only to the registered holders of the debt securities.  Cardinal Health does not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means and who are, therefore, not the registered holders of the debt securities.  This will be the case whether an investor chooses to be an indirect holder of a debt security, or has no choice in the matter because Cardinal Health is issuing the debt securities only in global form.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">For example, once Cardinal Health makes a payment or gives a notice to the registered holder of the debt securities, Cardinal Health has no further responsibility with respect to such payment or notice even if that registered holder is required, under agreements with depositary participants or customers or by law, to pass it along to the indirect holders but does not do so.  Similarly, if Cardinal Health wants to obtain the approval of the holders for any purpose (for example, to amend an indenture or to relieve Cardinal Health of the consequences of a default or of our obligation to comply with a particular provision of an indenture), Cardinal Health would seek the approval only from the registered holders, and not the indirect holders, of the debt securities.  Whether and how the registered holders contact the indirect holders is up to the registered holders.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Notwithstanding the above, when Cardinal Health refers to &#8220;you&#8221; or &#8220;your&#8221; in this prospectus, Cardinal Health is referring to investors who invest in the debt securities being offered by this prospectus, whether they are the registered holders or only indirect holders of the debt securities offered.  When Cardinal Health refers to &#8220;your debt securities&#8221; in this prospectus, Cardinal Health means the series of debt securities in which you hold a direct or indirect interest.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Special Considerations for Indirect Holders</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If you hold debt securities through a bank, broker or other financial institution, either in book-entry form or in street name, Cardinal Health urges you to check with that institution to find out:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">how it handles securities payments and notices;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">whether it imposes fees or charges;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">how it would handle a request for its consent, as a registered holder of the debt securities, if ever required;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if permitted for a particular series of debt securities, whether and how you can instruct it to send you debt securities registered in your own name so you can be a registered holder of such debt securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">how it would exercise rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if the debt securities are in book-entry form, how the depositary&#8217;s rules and procedures will affect these matters.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Global Securities</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A global security represents one or any other number of individual debt securities.  Generally, all debt securities represented by the same global securities will have the same terms.  Each debt security issued in book-entry form will be represented by a global security that Cardinal Health deposits with and registers in the name of a financial institution or its nominee that Cardinal Health selects.  The financial institution that Cardinal Health selects for this purpose is called the depositary.  Unless Cardinal Health specifies otherwise in the applicable prospectus supplement, The Depository Trust&#160;Company, New York, New York, known as DTC, will be the depositary for all debt securities that Cardinal Health issues in book-entry form.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A global security may not be transferred to or registered in the name of anyone other than the depositary or its nominee, unless special termination situations arise.  Cardinal Health describes those situations below under &#8220;&#8212;&#160;Special Situations When a Global Security Will Be Terminated.&#8221;  As a result of these arrangements, the depositary, or its nominee, will be the sole registered holder of all debt securities represented by a global security, and investors will be permitted to own only beneficial interests in a global security.  Beneficial interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account either with the depositary or with another institution that has an account with the depositary.  Thus, an investor whose security is represented by a global security will not be a registered holder of the debt security, but an indirect holder of a beneficial interest in the global security.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Special Considerations for Global Securities</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">As an indirect holder, an investor&#8217;s rights relating to a global security will be governed by the account rules of the investor&#8217;s financial institution and of the depositary, as well as general laws relating to securities transfers.  The depositary that holds the global security will be considered the registered holder of the debt securities represented by such global security.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If debt securities are issued only in the form of a global security, an investor should be aware of the following:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">An investor cannot cause the debt securities to be registered in his or her name, and cannot obtain non-global certificates for his or her interest in the debt securities, except in the special situations we describe below under &#8220;&#8212; Special Situations When a Global Security Will Be Terminated.&#8221;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">An investor will be an indirect holder and must look to his or her own bank or broker for payments on the debt securities and protection of his or her legal rights relating to the debt securities, as we describe under &#8220;&#8212; Holders of Registered Debt Securities&#8221; above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">An investor may not be able to sell his or her interest in the debt securities to some insurance companies and other institutions that are required by law to own their securities in non-book-entry form.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">An investor may not be able to pledge his or her interest in the debt securities in circumstances where certificates representing the debt securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">ownership interests in a global security.  Additionally, neither the trustee nor Cardinal Health supervise the depositary in any way.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">DTC requires that those who purchase and sell interests in a global security that is deposited in its book-entry system use immediately available funds.  Your broker or bank may also require you to use immediately available funds when purchasing or selling interests in a global security.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Financial institutions that participate in the depositary&#8217;s book-entry system, and through which an investor holds its interest in a global security, may also have their own policies affecting payments, notices and other matters relating to the debt security.  There may be more than one financial intermediary in the chain of ownership for an investor.  Cardinal Health does not monitor and is not responsible for the actions of any of such intermediaries.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Special Situations When a Global Security Will Be Terminated</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In a few special situations described below, a global security will be terminated and interests in the global security will be exchanged for certificates in non-global form, referred to as &#8220;certificated&#8221; debt securities.  After such an exchange, it will be up to the investor as to whether to hold the certificated debt securities directly or in street name.  Cardinal Health has described the rights of direct holders and street name holders under &#8220;&#8212;&#160;Holders of Registered Debt Securities&#8221; above.  Investors must consult their own banks or brokers to find out how to have their interests in a global security exchanged on termination of a global security for certificated debt securities to be held directly in their own names.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The special situations for termination of a global security are as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if the depositary notifies Cardinal Health that it is unwilling, unable or no longer qualified to continue as depositary for that global security, and Cardinal Health does not appoint another institution to act as depositary within 90 days of such notification;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if Cardinal Health notifies the trustee that it wishes to terminate that global security; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if an event of default has occurred with regard to the debt securities represented by that global security and such event of default has not been cured or waived.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The applicable prospectus supplement may list situations for terminating a global security that would apply only to the particular series of debt securities covered by such prospectus supplement.  If a global security were terminated, only the depositary, and not Cardinal Health or the trustee, would be responsible for deciding the names of the institutions in whose names the debt securities represented by the global security would be registered and, therefore, who would be the registered holders of those debt securities.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Form, Exchange and Transfer of Registered Securities</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If we cease to issue registered debt securities in global form, we will issue them:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">only in fully registered certificated form; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">unless otherwise indicated in the applicable prospectus supplement, in denominations of $1,000 and amounts that are multiples of $1,000.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Holders may exchange their certificated securities for debt securities of smaller denominations or combined into fewer debt securities of larger denominations, as long as the total principal amount is not changed.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Holders may exchange or transfer their certificated securities at the trustee&#8217;s office.  Cardinal Health has appointed the trustee to act as its agent for registering debt securities in the names of holders transferring debt securities.  Cardinal Health may appoint another entity to perform these functions or perform them itself.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Holders will not be required to pay a service charge to transfer or exchange their certificated securities, but they may be required to pay any tax or other governmental charge associated with the transfer or exchange.  The transfer or exchange will be made only if Cardinal Health&#8217;s transfer agent is satisfied with the holders proof of legal ownership.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If Cardinal Health has designated additional transfer agents for your debt security, they will be named in the applicable prospectus supplement.  Cardinal Health may appoint additional transfer agents or cancel the appointment of any particular transfer agent.  Cardinal Health may also approve a change in the location of the office through which any transfer agent acts.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If any certificated securities of a particular series are redeemable and Cardinal Health redeems less than all the debt securities of that series, Cardinal Health may block the transfer or exchange of those debt securities during the period beginning 15&#160;days before the day Cardinal Health mails the notice of redemption and ending on the day of that mailing, in order to freeze the list of holders to prepare the mailing.  Cardinal Health may also refuse to register transfers or exchanges of any certificated securities selected for redemption, except that Cardinal Health will continue to permit transfers and exchanges of the unredeemed portion of any debt security that will be partially redeemed.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If a registered debt security is issued in global form, only the depositary will be entitled to transfer and exchange the debt security as described in this subsection because it will be the sole holder of the debt security.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Payment and Paying Agents</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">On each due date for interest payments on the debt securities, Cardinal Health will pay interest to each person shown on the trustee&#8217;s records as owner of the debt securities at the close of business on a designated day that is in advance of the due date for interest.  Cardinal Health will pay interest to each such person even if such person no longer owns the debt security on the interest due date.  The designated day on which Cardinal Health will determine the owner of the debt security, as shown on the trustee&#8217;s records, is also known as the &#8220;record date.&#8221;  The record date will usually be about two weeks in advance of the interest due date.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Because Cardinal Health will pay interest on the debt securities to the holders of the debt securities based on ownership as of the applicable record date with respect to any given interest period, and not to the holders of the debt securities on the interest due date (that is, the day that the interest is to be paid), it is up to the holders who are buying and selling the debt securities to work out between themselves the appropriate purchase price for the debt securities.  It is common for purchase prices of debt securities to be adjusted so as to prorate the interest on the debt securities fairly between the buyer and the seller based on their respective ownership periods within the applicable interest period.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Payments on Global Securities</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health will make payments on a global security by wire transfer of immediately available funds directly to the depositary, or its nominee, and not to any indirect holders who own beneficial interests in the global security.  An indirect holder&#8217;s right to those payments will be governed by the rules and practices of the depositary and its participants, as described under &#8220;&#8212;&#160;Global Securities&#8221; above.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Payments on Certificated Securities</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health will make interest payments on debt securities held in certificated form by mailing a check on each due date for interest payments to the holder of the certificated securities, as shown on the trustee&#8217;s records, as of the close of business on the record date.  Cardinal Health will make all payments of principal and premium, if any, on the certificated securities by check at the office of the trustee in New York City, New York, and/or at other offices that may be specified in the applicable prospectus supplement or in a notice to holders, against surrender of the certificated security.  All payments by check will be made in next-day funds (that is, funds that become available on the day after the check is cashed).</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Alternatively, if a certificated security has a face amount of at least $10,000,000, and the holder of such certificated security so requests, Cardinal Health will pay any amount that becomes due on such certificated security by wire transfer of immediately available funds to an account specified by the holder at a bank in New York City, New York, on the applicable due date for payment.  To request payment by wire transfer, the holder must give appropriate transfer instructions to the trustee or other paying agent at least 15 business days before the requested wire payment is due.  In the case of any interest payments, the instructions must be given by the person who is shown on the trustee&#8217;s records as the holder of the certificated security on the applicable record date.  Wire instructions, once properly given, will remain in effect unless and until new instructions are given in the manner described above.</font></div><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;font-weight:bold;">Payment When Offices Are Closed</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If payment on a debt security is due on a day that is not a business day, Cardinal Health will make such payment on the next succeeding business day.  The indenture will provide that such payments will be treated as if they were made on the original due date for payment.  A postponement of this kind will not result in a default under any debt security or indenture, and no interest will accrue on the amount of any payment that is postponed in this manner.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Book-entry and other indirect holders should consult their banks or brokers for information on how they will receive payments on their debt securities.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Governing Law</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The indenture is governed by New York law.</font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">The Trustee</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The trustee under the indenture is The Bank of New York Mellon Trust Company, N.A. The trustee serves as trustee for Cardinal Health's 1.700% Notes due 2018, 1.900% Notes due 2017, 1.95% Notes due 2018, 2.4% Notes due 2019, 3.200% Notes due 2022, 3.200% Notes due 2023, 3.5% Notes due 2024, 3.75% Notes due 2025, 4.5% Notes due 2044, 4.600% Notes due 2043, 4.625% Notes due 2020 and 4.9% </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">22</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Notes due 2045. The trustee also serves as trustee for Allegiance Corporation's 7.000% Debentures due 2026, which are guaranteed by Cardinal Health.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">23</font></div></div><hr style="page-break-after:always"><div><a name="s608C36D51CD947A2D978FB26AF8FFA32"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">VALIDITY OF THE SECURITIES</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The validity of the offered securities will be passed upon for us by Gibson, Dunn &amp; Crutcher LLP, New York, New York and John M. Adams, Jr. of Cardinal Health.  Mr. Adams is paid a salary by Cardinal Health and participates in various employee benefit plans offered to Cardinal Health's employees generally.  Mr. Adams holds equity incentive awards with respect to Cardinal Health's common shares valued at greater than $50,000.  Certain legal matters with respect to the offered securities may be passed upon by counsel for any underwriters, dealers or agents, each of whom will be named in the related prospectus supplement.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">24</font></div></div><hr style="page-break-after:always"><div><a name="s8E9AC3896C99C7463FB5FB26AF9A3FD0"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">EXPERTS</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The consolidated financial statements of Cardinal Health, Inc. and subsidiaries appearing in Cardinal Health, Inc.'s Annual Report (Form 10-K) for the year ended June 30, 2016 (including the schedule appearing therein) and the effectiveness of Cardinal Health Inc. and subsidiaries' internal control over financial reporting as of June 30, 2016, have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference.  Such consolidated financial statements are, and audited consolidated financial statements to be included in subsequently filed documents will be, incorporated herein in reliance upon the reports of Ernst &amp; Young LLP pertaining to such consolidated financial statements and the effectiveness of our internal control over financial reporting as of the respective dates (to the extent covered by consents filed with the SEC) given on the authority of such firm as experts in accounting and auditing.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">25</font></div></div><hr style="page-break-after:always"><div><a name="s2395976A03571BC05242FB26AFC29352"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;font-weight:bold;">PLAN OF DISTRIBUTION</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health may sell the offered securities:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">through the solicitation of proposals of underwriters or dealers to purchase the offered securities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">through underwriters or dealers on a negotiated basis;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">directly to institutional investors</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">directly to a limited number of purchasers or to a single purchaser; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">through agents; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">through a combination of any of these methods of sale.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The prospectus supplement with respect to any offered securities will set forth the terms of the offering, including the name or names of any underwriters, dealers or agents, the purchase price of the offered securities and the proceeds to Cardinal Health from such sale, any underwriting discounts and commissions and other items constituting underwriters&#8217; compensation, any initial public offering price and any discounts or concessions allowed or reallowed or paid to dealers, and any securities exchange on which such offered securities may be listed.  Any initial public offering price, discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The securities may be offered and sold through agents that we may designate from time to time.  Unless otherwise indicated in the applicable prospectus supplement, any such agent will be acting on a best efforts basis for the period of its appointment.  Any such agent may be deemed to be an underwriter, as that term is defined in the Securities Act, of any securities so offered and sold.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If an underwriter or underwriters are utilized in the sale of any offered securities, Cardinal Health will execute an underwriting agreement with such underwriter or underwriters, and the names of the underwriter or underwriters and the terms of the transactions, including commissions, discounts, and any other compensation of the underwriters and dealers, if any, will be set forth in the prospectus supplement that will be used by the underwriters to make resales of the offered securities.  Such underwriter or underwriters will acquire the offered securities for their own account and may resell such offered securities from time to time in one or more transactions, including negotiated transactions, at fixed public offering prices or at varying prices determined at the time of sale.  The securities may be offered to the public either through underwriting syndicates represented by managing underwriters or by underwriters without a syndicate.  If any underwriter or underwriters are utilized in the sale of any offered securities, unless otherwise set forth in the applicable prospectus supplement, the underwriting agreement will provide that the obligations of the underwriters will be subject to certain conditions precedent and that the underwriters with respect to a sale of such offered securities will be obligated to purchase all such offered securities if any are purchased.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If so indicated in the prospectus supplement or term sheet relating to a particular series or issue of offered securities, we will authorize underwriters, dealers or agents to solicit offers by certain institutions to purchase the offered securities from us under delayed delivery contracts providing for payment and delivery at a future date.  These contracts will be subject only to those conditions set forth in the prospectus supplement or term sheet, and the prospectus supplement or term sheet will set forth the commission payable for solicitation of these contracts.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">If a dealer is utilized in the sale of any offered securities, Cardinal Health will sell such offered securities to the dealer, as principal.  The dealer may then resell such offered securities to the public at varying prices to be determined by such dealer at the time of resale.  Any such dealer may be deemed to be an underwriter, as such term is defined in the Securities Act, of the securities so offered and sold.  The name of any such dealer and the terms of the transaction will be set forth in a prospectus supplement relating thereto.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Offers to purchase securities may be solicited directly by Cardinal Health and sales thereof may be made by Cardinal Health directly to institutional investors or others, who may be deemed to be underwriters, as such term is defined in the Securities Act, with respect to any resale of the offered securities.  The terms of any such sales will be described in a prospectus supplement relating thereto.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health may indemnify its agents, dealers and underwriters against certain civil liabilities, including liabilities under the Securities Act, or contribute to payments which such agents, dealers or underwriters may be required to make in respect thereof.  Agents, dealers and underwriters may be customers of, engage in transactions with, or perform services for us in the ordinary course of business.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Unless otherwise indicated in the applicable prospectus supplement, all securities offered by this prospectus, other than Cardinal Health&#8217;s common shares, which are listed on the New York Stock Exchange, will be new issues with no established trading market.  Cardinal Health may elect to list any series of securities on an exchange, and in the case of Cardinal Health&#8217;s common shares, on any additional exchange, but, unless otherwise specified in the applicable prospectus supplement, Cardinal Health shall not be obligated to do so.  In addition, underwriters will not be obligated to make a market in any securities.  No assurance can be given regarding the activity of trading in, or liquidity of, any securities.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any underwriter may engage in over-allotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Exchange Act.  Over-allotment involves sales in excess of the offering size, which creates a short position.  Stabilizing </font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">26</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum.  Short covering transactions involve purchases of the securities in the open market after the distribution is completed to cover short positions.  Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a covering transaction to cover short positions.  Those activities may cause the price of the securities to be higher than it would otherwise be.  If commenced, the underwriters may discontinue any of those activities at any time.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">27</font></div></div><hr style="page-break-after:always"><div><a name="sEBA8FC1BFE329145324EFB26AFE415D9"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;background-color:#ffffff;font-weight:bold;">PART II</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;background-color:#ffffff;font-weight:bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</font></div><div><a name="s0A09760EF117E0855D8BFB26B0166A29"></a></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Item 14.&#160;&#160;&#160;&#160;</font><font style="font-family:Arial Narrow;font-size:12pt;font-style:italic;font-weight:bold;">Other Expenses of Issuance and Distribution</font><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:2%;"></td><td style="width:90%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">SEC Registration Fee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Stock Exchange Listing Fee</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Trustees Expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Printing and Engraving</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Services of Counsel</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Services of Independent Public Accountants</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Rating Agency Fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Blue Sky Fees and Expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Miscellaneous</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">*</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Estimated</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Deferred in reliance upon Rule 456(b) and 457(r).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The applicable prospectus supplement will set forth the estimated aggregate amount of expenses payable with respect to any offering of securities.</font></div></td></tr></table><div><a name="s8CE835741BAC25FA561AFB26B0374E03"></a></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Item 15.&#160;&#160;&#160;&#160;</font><font style="font-family:Arial Narrow;font-size:12pt;font-style:italic;font-weight:bold;">Indemnification of Directors and Officers</font><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Section 1701.13(E) of the Ohio Revised Code sets forth conditions and limitations governing the indemnification of directors, officers and certain other persons.  In general, the Ohio Revised Code authorizes Ohio corporations to indemnify directors, officers and certain other persons from liability if the director, officer or certain other person acted in good faith and in a manner reasonably believed by the director, officer or certain other person to be in or not opposed to the best interests of the corporation, and, with respect to any criminal actions, if the director, officer or certain other person had no reasonable cause to believe his or her conduct was unlawful.  In the case of an action by or on behalf of a corporation, indemnification may not be made (i) if the person seeking indemnification is adjudged liable for negligence or misconduct, unless an appropriate court determines such person is fairly and reasonably entitled to indemnification, or (ii) if liability asserted against such person concerns certain unlawful dividends, distributions and other payments.  Section 1701.13(E) provides that to the extent a director, officer or certain other person has been successful on the merits or otherwise in defense of any such action, suit or proceeding, such individual shall be indemnified against expenses reasonably incurred in connection therewith.  The indemnification authorized under Ohio law is not exclusive and is in addition to any other rights granted to directors, officers or certain other persons under the articles of incorporation or code of regulations of the corporation or an agreement.  A corporation may purchase and maintain insurance or furnish similar protection on behalf of any director, officer or certain other person against any liability asserted against him or her and incurred by him or her in his or her capacity, or arising out of the status, as a director, officer or certain other person, whether or not the corporation would have the power to indemnify him against such liability under the Ohio Revised Code.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Article 5 of the Regulations contains certain indemnification provisions adopted pursuant to authority contained in Section 1701.13(E) of the Ohio Revised Code.  The Regulations provide that Cardinal Health shall, to the fullest extent authorized by law, including but not limited to the laws of the State of Ohio, indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative, by reason of the fact that he or she is or was a director, officer, or employee of Cardinal Health, or is or was serving at the written request of Cardinal Health as a director, trustee, officer, employee, member, or manager of another corporation, domestic or foreign, nonprofit or for profit, limited liability company, partnership, joint venture, trust, or other enterprise, against expenses, including attorneys&#8217; fees, judgments, fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit, or proceeding.  No amendment, termination, or repeal of Article 5, nor, to the fullest extent permitted by law, any modification of law, shall adversely affect or impair in any way the rights to be indemnified or to advancement of expenses pursuant to Article 5 with respect to any actions, omissions, transactions or facts occurring prior to the final adoption of such amendment, modification, termination or repeal.  Cardinal Health has also entered into indemnification contracts with certain of its directors and officers which have terms similar to the indemnification provisions set forth in the Regulations.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health maintains a directors&#8217; and officers&#8217; insurance policy that insures the officers and directors of Cardinal Health from claims arising out of an alleged wrongful act by such persons in their respective capacities as officers and directors of Cardinal Health.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">II-1</font></div></div><hr style="page-break-after:always"><div><a name="sE1BC90E1E18D135D1A36FB26B06992A7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Item 16.&#160;&#160;&#160;&#160;</font><font style="font-family:Arial Narrow;font-size:12pt;font-style:italic;font-weight:bold;">Exhibits</font><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Form of Underwriting Agreement (1)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indenture, dated as of June&#160;2, 2008, between Cardinal Health and The Bank of New York Mellon Trust&#160;Company, N.A. (formerly The Bank of New York Trust&#160;Company, N.A.) (2)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. Amended and Restated Articles of Incorporation, as amended (3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. Restated Code of Regulations (4)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Form of Debt Securities (2)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.5</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Specimen of Certificate for Common Shares (5)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.6</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Specimen of Certificate for Preferred Shares (1)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">5.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Opinion of Gibson, Dunn &amp; Crutcher LLP as to validity of debt securities</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">5.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Opinion of John M. Adams, Jr., Associate General Counsel of Cardinal Health, Inc., as to validity of common shares and preferred shares</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">12</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Computation of Ratio of Earnings to Fixed Charges (6)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">23.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Consent of Ernst&#160;&amp; Young LLP</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">23.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Consent of Gibson, Dunn &amp; Crutcher LLP (included in Exhibit&#160;5.1)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">23.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Consent of John M. Adams, Jr., Associate General Counsel of Cardinal Health, Inc. (included in Exhibit&#160;5.2)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">24</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Powers of Attorney (included on signature page)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">25</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Form&#160;T-1 Statement of Eligibility under the Trust&#160;Indenture Act of 1939, as amended, of The Bank of New York Mellon Trust&#160;Company, N.A.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:6pt;"><font style="font-family:Arial Narrow;font-size:6pt;background-color:#ffffff;">___________________________</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;background-color:#ffffff;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To be filed by amendment or as an exhibit to a document to be incorporated or deemed to be incorporated by reference in the registration statement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 4.1 to the registrant&#8217;s Current Report on Form&#160;8-K (File No. 001-11373), dated June&#160;2, 2008 and incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 3.1 to the registrant&#8217;s Quarterly Report on Form&#160;10-Q for the quarter ended September&#160;30, 2008 (File No.&#160;001-11373), incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 3.2 to Cardinal Health&#8217;s Current Report on Form 8-K (File No. 001-11373), dated June 30, 2016 and incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 4.9 to Cardinal Health&#8217;s Registration Statement on Form&#160;S-3 (File No. 333-62944), dated June 13, 2001 and incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 12.1 to Cardinal Health&#8217;s Quarterly Report on Form&#160;10-Q for the quarter ended December&#160;31, 2016 (File No.&#160;001-11373) and incorporated herein by reference.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">II-2</font></div></div><hr style="page-break-after:always"><div><a name="s8A55C643B852A6201790FB26B08C7FC8"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">Item 17.&#160;&#160;&#160;&#160;</font><font style="font-family:Arial Narrow;font-size:12pt;font-style:italic;font-weight:bold;">Undertakings</font><font style="font-family:Arial Narrow;font-size:12pt;font-weight:bold;">.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The undersigned registrant hereby undertakes:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.  Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">&#8220;Calculation of Registration Fee&#8221;</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;table in the effective registration statement;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">provided</font><font style="font-family:Arial Narrow;font-size:10pt;">, </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">however</font><font style="font-family:Arial Narrow;font-size:10pt;">, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) do not apply if the registration statement is on Form&#160;S-3 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration statement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">bona fide</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;offering thereof.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Each prospectus filed by the registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus.  As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">bona fide</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;offering thereof.  </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">Provided, however</font><font style="font-family:Arial Narrow;font-size:10pt;">, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(i)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(ii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">II-3</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(iii)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant;&#160;and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial Narrow;font-size:10pt;">(iv)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(b)&#160;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-family:Arial Narrow;font-size:10pt;font-style:italic;">bona fide</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;offering thereof.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers, and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">II-4</font></div></div><hr style="page-break-after:always"><div><a name="s6D7602D4C901C1D0330BFB26B0BC5CCD"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;background-color:#ffffff;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&#160;S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Dublin, State of Ohio, on February 7, 2017.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:41%;"></td><td style="width:5%;"></td><td style="width:54%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Cardinal Health, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;GEORGE S. BARRETT</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">George S. Barrett</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Chairman and Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints George S. Barrett, Michael C. Kaufmann and Jessica L. Mayer, and each of them, severally, as his/her attorney-in-fact and agent, with full power of substitution and re-substitution, for him/her and in his/her name, place, and stead, in any and all capacities, to sign and file any and all amendments (including any post effective amendments) to this registration statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he/she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities indicated on February 7, 2017.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:39%;"></td><td style="width:4%;"></td><td style="width:57%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Title</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;GEORGE S. BARRETT</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chairman and Chief Executive Officer (principal executive officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">George S. Barrett</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;MICHAEL C. KAUFMANN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Chief Financial Officer (principal financial officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Michael C. Kaufmann</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;STUART G. LAWS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Senior Vice President and Chief Accounting Officer (principal accounting officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Stuart G. Laws</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;DAVID J. ANDERSON</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">David J. Anderson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;COLLEEN F. ARNOLD</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Colleen F. Arnold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;CARRIE S. COX</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Carrie S. Cox</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;CALVIN DARDEN</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Calvin Darden</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;BRUCE L. DOWNEY</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Bruce L. Downey</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;PATRICIA A. HEMINGWAY HALL</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Patricia A. Hemingway Hall</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Clayton M. Jones</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;GREGORY B. KENNY</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Gregory B. Kenny</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">II-5</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:39%;"></td><td style="width:4%;"></td><td style="width:57%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Title</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;NANCY KILLEFER</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Nancy Killefer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/&#160;&#160;&#160;&#160;DAVID P. KING</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">David P. King</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">II-6</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;" href="#s89C002B2989B396915D4FB26AD9D1CF5"><font style="font-family:Arial Narrow;font-size:8pt;text-decoration:underline;">Table of Contents</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;background-color:#ffffff;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:7%;"></td><td style="width:93%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit Description</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Form of Underwriting Agreement (1)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Indenture, dated as of June&#160;2, 2008, between Cardinal Health and The Bank of New York Mellon Trust&#160;Company, N.A. (formerly The Bank of New York Trust&#160;Company, N.A.) (2)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. Amended and Restated Articles of Incorporation, as amended (3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc. Restated Code of Regulations (4)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Form of Debt Securities (2)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.5</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Specimen of Certificate for Common Shares (5)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">4.6</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Specimen of Certificate for Preferred Shares (1)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">5.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Opinion of Gibson, Dunn &amp; Crutcher LLP as to validity of debt securities</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">5.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Opinion of John M. Adams, Jr., Associate General Counsel of Cardinal Health, Inc., as to validity of common shares and preferred shares</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">12</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Computation of Ratio of Earnings to Fixed Charges (6)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">23.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Consent of Ernst&#160;&amp; Young LLP</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">23.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Consent of Gibson, Dunn &amp; Crutcher LLP (included in Exhibit&#160;5.1)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">23.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Consent of John M. Adams, Jr., Associate General Counsel of Cardinal Health, Inc. (included in Exhibit&#160;5.2)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">24</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Powers of Attorney (included on signature page)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">25</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Form&#160;T-1 Statement of Eligibility under the Trust&#160;Indenture Act of 1939, as amended, of The Bank of New York Mellon Trust&#160;Company, N.A.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:6pt;"><font style="font-family:Arial Narrow;font-size:6pt;background-color:#ffffff;">___________________________</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;background-color:#ffffff;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">To be filed by amendment or as an exhibit to a document to be incorporated or deemed to be incorporated by reference in the registration statement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 4.1 to the registrant&#8217;s Current Report on Form&#160;8-K (File No. 001-11373), dated June&#160;2, 2008 and incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 3.1 to the registrant&#8217;s Quarterly Report on Form&#160;10-Q for the quarter ended September&#160;30, 2008 (File No.&#160;001-11373), incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 3.2 to Cardinal Health&#8217;s Current Report on Form 8-K (File No. 001-11373), dated June 30, 2016 and incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 4.9 to Cardinal Health&#8217;s Registration Statement on Form&#160;S-3 (File No. 333-62944), dated June 13, 2001 and incorporated herein by reference.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Filed as Exhibit 12.1 to Cardinal Health&#8217;s Quarterly Report on Form&#160;10-Q for the quarter ended December 31, 2016 (File No.&#160;001-11373) and incorporated herein by reference.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">II-7</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>forms-3asrexhibit511.htm
<DESCRIPTION>OPINION OF GIBSON, DUNN & CRUTCHER LLP
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s39D1F66B8AC507FD782EFBDE0D9B02D3"></a></div><div><div style="line-height:120%;text-align:right;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Exhibit 5.1</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="gibsonheadera01.jpg" alt="gibsonheadera01.jpg" style="height:77px;width:768px;"></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">February 7, 2017</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cardinal Health, Inc.</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">7000 Cardinal Place <br>Dublin, OH 43017</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;">Re:</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cardinal Health, Inc. <br>Registration Statement on Form S-3</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Ladies and Gentlemen:</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have acted as counsel to Cardinal Health, Inc., an Ohio corporation (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Company</font><font style="font-family:inherit;font-size:12pt;">&#8221;), in connection with the preparation and filing with the Securities and Exchange Commission (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Commission</font><font style="font-family:inherit;font-size:12pt;">&#8221;) of a Registration Statement on Form S-3 (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Registration Statement</font><font style="font-family:inherit;font-size:12pt;">&#8221;) under the Securities Act of 1933, as amended (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities Act</font><font style="font-family:inherit;font-size:12pt;">&#8221;), relating to the registration under the Securities Act and the proposed issuance and sale from time to time pursuant to Rule 415 under the Securities Act, together or separately and in one or more series (if applicable) of: </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:12pt;">the Company&#8217;s common shares, without par value (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Common Shares</font><font style="font-family:inherit;font-size:12pt;">&#8221;); </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(ii)</font><font style="font-family:inherit;font-size:12pt;">the Company&#8217;s preferred shares, without par value (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Preferred Shares</font><font style="font-family:inherit;font-size:12pt;">&#8221;); and</font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(iii)</font><font style="font-family:inherit;font-size:12pt;">the Company&#8217;s unsecured debt securities, which may either be senior debt securities or subordinated debt securities (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Debt Securities</font><font style="font-family:inherit;font-size:12pt;">&#8221;).</font></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Common Shares, Preferred Shares and Debt Securities are collectively referred to herein as the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Securities</font><font style="font-family:inherit;font-size:12pt;">.&#8221;  The Debt Securities are to be issued under an indenture (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Base Indenture</font><font style="font-family:inherit;font-size:12pt;">&#8221;) entered into</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly The Bank of New York Trust Company), as indenture trustee. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In arriving at the opinion expressed below, we have examined originals, or copies certified or otherwise identified to our satisfaction as being true and complete copies of the originals, of the Base Indenture, forms of the Debt Securities and such other documents, corporate records, certificates of officers of the Company and of public officials and other instruments as we have deemed necessary or advisable to enable us to render this opinion. In our examination, we have assumed the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as copies. As to any facts material to this opinion, we have relied to the extent we deemed </font></div><div><br></div><div><div style="line-height:120%;text-align:center;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;"><img src="locationfooter.jpg" alt="locationfooter.jpg" style="height:30px;width:489px;"></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sb38a7c727bb44f94bfc2e90bb46bea7d"></a></div><div><div style="line-height:120%;text-align:left;"><img src="a1022461483cah2017s3e_image1.jpg" alt="a1022461483cah2017s3e_image1.jpg" style="height:22px;width:222px;"></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cardinal Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">February 7, 2017</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page </font><font style="font-family:inherit;font-size:12pt;">2</font></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">appropriate and without independent investigation upon statements and representations of officers and other representatives of the Company</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">and others. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We are not admitted or qualified to practice law in the State of Ohio. Therefore, we have relied upon the opinion of John M. Adams, Jr., Associate General Counsel of the Company, with respect to matters governed by the laws of the State of Ohio.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We have assumed without independent investigation that: </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(i)</font><font style="font-family:inherit;font-size:12pt;">at the time any Securities are sold pursuant to the Registration Statement (the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Relevant Time</font><font style="font-family:inherit;font-size:12pt;">&#8221;), the Registration Statement and any supplements and amendments thereto (including post-effective amendments) will be effective and will comply with all applicable laws; </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(ii)</font><font style="font-family:inherit;font-size:12pt;">at the Relevant Time, a prospectus supplement will have been prepared and filed with the Commission describing the Securities offered thereby and all related documentation and will comply with all applicable laws; </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(iii)</font><font style="font-family:inherit;font-size:12pt;">all Securities will be issued and sold in the manner stated in the Registration Statement and the applicable prospectus supplement; </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(iv)</font><font style="font-family:inherit;font-size:12pt;">at the Relevant Time, all corporate or other action required to be taken by the Company to duly authorize each proposed issuance of Securities and any related documentation (including (i) the due reservation of any Common Shares or Preferred Shares for issuance upon exercise, conversion or exchange of any Securities for Common Shares or Preferred Shares (a &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Convertible Security</font><font style="font-family:inherit;font-size:12pt;">&#8221;), and (ii) the execution (in the case of certificated Securities), delivery and performance of the Securities and any related documentation referred to in the opinion below) shall have been duly completed and shall remain in full force and effect; </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(v)</font><font style="font-family:inherit;font-size:12pt;">upon issuance of any Common Shares or Preferred Shares upon exercise, conversion or exchange of any Convertible Security, the total number of Common Shares or Preferred Shares issued and outstanding will not exceed the total number of Common Shares or Preferred Shares, as applicable, that the Company is then authorized to issue under its articles of incorporation and other relevant documents; </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(vi)</font><font style="font-family:inherit;font-size:12pt;">in the case of Debt Securities, at the Relevant Time, the Base Indenture shall have been duly qualified under the Trust Indenture Act of 1939; and </font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:48px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">(vii)</font><font style="font-family:inherit;font-size:12pt;">at the Relevant Time, a definitive purchase, underwriting or similar agreement and any other necessary agreement with respect to any Securities offered or issued will have </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;"><img src="a1022461483cah2017s3e_image1.jpg" alt="a1022461483cah2017s3e_image1.jpg" style="height:22px;width:222px;"></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cardinal Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">February 7, 2017</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page </font><font style="font-family:inherit;font-size:12pt;">3</font></div></div><div><br></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;"><font style="font-family:inherit;font-size:12pt;">been duly authorized by all necessary corporate or other action of the Company and duly executed and delivered by the Company and the other parties thereto. </font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Based on the foregoing and in reliance thereon, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that, with respect to any Debt Securities, when: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">a.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">the terms and conditions of such Debt Securities have been duly established by supplemental indenture or officers&#8217; certificate in accordance with the terms and conditions of the relevant Base Indenture, </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">b.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">any such supplemental indenture has been duly executed and delivered by the Company and the relevant trustee (together with the relevant Base Indenture, the &#8220;</font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Indenture</font><font style="font-family:inherit;font-size:12pt;">&#8221;), and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">c.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">such Debt Securities have been executed (in the case of certificated Debt Securities), delivered and authenticated in accordance with the terms of the applicable Indenture and issued and sold for the consideration set forth in the applicable definitive purchase, underwriting or similar agreement, </font></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">such Debt Securities will be legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The opinion expressed above is subject to the following exceptions, qualifications, limitations and assumptions:</font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:96px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">A.</font><font style="font-family:inherit;font-size:12pt;">We render no opinion herein as to matters involving the laws of any jurisdiction other than the State of New York. This opinion is limited to the effect of the current state of the laws of the State of New York and the facts as they currently exist. We assume no obligation to revise or supplement this opinion in the event of future changes in such laws or the interpretations thereof or such facts.</font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:96px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">B.</font><font style="font-family:inherit;font-size:12pt;">The opinion above is subject to (i) the effect of any bankruptcy, insolvency, reorganization, moratorium, arrangement or similar laws affecting the rights and remedies of creditors&#8217; generally, including without limitation the effect of statutory or other laws regarding fraudulent transfers or preferential transfers, and (ii) general principles of equity, including without limitation concepts of materiality, reasonableness, good faith and fair dealing and the possible unavailability of specific performance, injunctive relief or other equitable remedies regardless of whether enforceability is considered in a proceeding in equity or at law.</font></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;text-indent:96px;"><font style="padding-top:16px;text-align:left;font-family:inherit;font-size:12pt;padding-right:48px;">C.</font><font style="font-family:inherit;font-size:12pt;">We express no opinion regarding the effectiveness of (i) any waiver of stay, extension or usury laws; (ii) provisions relating to indemnification, exculpation or </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;"><img src="a1022461483cah2017s3e_image1.jpg" alt="a1022461483cah2017s3e_image1.jpg" style="height:22px;width:222px;"></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cardinal Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">February 7, 2017</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Page </font><font style="font-family:inherit;font-size:12pt;">4</font></div></div><div><br></div><div style="line-height:120%;padding-left:0px;padding-top:16px;text-align:left;"><font style="font-family:inherit;font-size:12pt;">contribution, to the extent such provisions may be held unenforceable as contrary to public policy or federal or state securities laws; or (iii) any provision to the effect that every right or remedy is cumulative and may be exercised in addition to any other right or remedy or that the election of some particular remedy does not preclude recourse to one or more others.</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the caption &#8220;Validity of the Securities&#8221; in the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Very truly yours,</font></div><div style="line-height:120%;padding-bottom:64px;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">/s/ GIBSON, DUNN &amp; CRUTCHER LLP</font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>3
<FILENAME>forms-3asrexhibit521.htm
<DESCRIPTION>OPINION OF JOHN M. ADAMS, JR.
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sAE045F1174DBFFB60AF6141B972FF720"></a></div><div><div style="line-height:140%;padding-bottom:5px;text-align:right;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;font-weight:bold;">Exhibit 5.2</font></div><div style="line-height:140%;padding-bottom:5px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:140%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:100%;text-align:center;padding-left:66px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:82%;"></td><td style="width:18%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div><img src="cahlogocoverlettera01.jpg" alt="cahlogocoverlettera01.jpg" style="height:81px;width:249px;"></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><font style="font-family:Arial;font-size:7.5pt;">Cardinal Health</font></div><div style="text-align:left;font-size:7.5pt;"><font style="font-family:Arial;font-size:7.5pt;">7000 Cardinal Place</font></div><div style="text-align:left;font-size:7.5pt;"><font style="font-family:Arial;font-size:7.5pt;">Dublin, OH 43017</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:7.5pt;">614.757.5000 main</font><font style="font-family:inherit;font-size:10pt;">&#160;<br></font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="text-align:left;font-size:7.5pt;"><font style="font-family:Arial;font-size:7.5pt;color:#ff0000;">cardinalhealth.com</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:center;padding-left:66px;text-indent:0px;font-size:7.5pt;"><font style="font-family:Arial;font-size:7.5pt;"><br></font></div><div style="line-height:120%;padding-bottom:32px;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">February 7, 2017</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Cardinal Health, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">7000 Cardinal Place</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Dublin, OH 43017</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Ladies and Gentlemen:</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">I am Associate General Counsel of Cardinal Health, Inc., an Ohio Corporation (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Company</font><font style="font-family:Arial;font-size:11pt;">&#8221;), and I have acted as counsel to the Company in connection with the preparation and filing by the Company of a registration statement on Form S-3 (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Registration Statement</font><font style="font-family:Arial;font-size:11pt;">&#8221;) with the Securities and Exchange Commission (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Commission</font><font style="font-family:Arial;font-size:11pt;">&#8221;) relating to the offering from time to time, pursuant to Rule 415 of the Securities Act of 1933, as amended (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Securities Act</font><font style="font-family:Arial;font-size:11pt;">&#8221;), of (i) common shares, without par value, of the Company (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Common Shares</font><font style="font-family:Arial;font-size:11pt;">&#8221;), (ii) preferred shares, without par value, of the Company (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Preferred Shares</font><font style="font-family:Arial;font-size:11pt;">&#8221;), and (iii) one or more series of debt securities of the Company (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Debt Securities</font><font style="font-family:Arial;font-size:11pt;">,&#8221; and together with the Common Shares and the Preferred Shares, the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Offered Securities</font><font style="font-family:Arial;font-size:11pt;">&#8221;).  The Debt Securities will be issued in one or more series pursuant to an Indenture dated as of June 2, 2008 (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Base Indenture</font><font style="font-family:Arial;font-size:11pt;">&#8221;), between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly The Bank of New York Trust Company, N.A.), as trustee (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Trustee</font><font style="font-family:Arial;font-size:11pt;">&#8221;), which is filed as an exhibit to the Company's Form 8-K dated June 2, 2008 and incorporated by reference as an exhibit to the Registration Statement.  The offering of the Offered Securities will be as set forth in the prospectus contained in the Registration Statement (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Prospectus</font><font style="font-family:Arial;font-size:11pt;">&#8221;), as supplemented by one or more supplements to the Prospectus.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">In rendering this opinion, I have examined the Registration Statement and the Indenture. I have also examined originals or copies, certified or otherwise identified to my satisfaction, of those documents and instruments filed as exhibits to the Registration Statement, such corporate records of the Company, certificates or documents and have made such other investigations and reviewed such questions of law as I have deemed necessary or appropriate for purposes of rendering this opinion.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">In the examination of the foregoing and in rendering this opinion, I have assumed the genuineness, without independent investigation, of all signatures on all documents, the legal capacity of each signatory to such documents, the conformity to original documents of all documents submitted for my examination as copies and the authenticity of all such documents.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Based on the foregoing, and subject to the qualifications hereinafter set forth, I am of the opinion that:</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:Arial;font-size:11pt;">1. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">The Common Shares will be validly issued, fully paid and non-assessable when: (a) final resolutions shall have been duly adopted pursuant to authority granted by the Company's Board of Directors, authorizing the issuance and sale of the Common Shares, in conformity with the Company's Amended and Restated Articles of </font></div></td></tr></table><div><br></div><div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-left:48px;padding-bottom:16px;text-align:left;"><font style="font-family:Arial;font-size:11pt;">Incorporation, as amended (the &#8220;</font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">Articles</font><font style="font-family:Arial;font-size:11pt;">&#8221;), and the Common Shares are issued in a manner consistent therewith and assuming the Company shall have such number of Common Shares as are included in such offering or sale authorized and available for issuance; (b) the certificates, if any, representing the Common Shares in the form of the specimen certificate examined by me shall have been duly executed, countersigned and registered; and (c) such Common Shares shall have been duly delivered to the purchasers thereof against payment of the agreed consideration therefor.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:Arial;font-size:11pt;">2. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">The Preferred Shares will be validly issued, fully paid and non-assessable when: (a) final resolutions shall have been duly adopted pursuant to authority granted by the Company's Board of Directors, authorizing the issuance and sale of the Preferred Shares, in conformity with the Articles, and the Preferred Shares are issued in a manner consistent therewith and assuming the Company shall have such number of Preferred Shares as are included in such offering or sale authorized and available for issuance; (b) all corporate action necessary for the issuance and sale of the shares of Preferred Shares has been taken, including the adoption and filing of an amendment to the Articles relating thereto; (c) the certificates, if any, representing the Preferred Shares in the form of the specimen certificate examined by me shall have been duly executed, countersigned and registered; and (d) such Preferred Shares shall have been duly delivered to the purchasers thereof against payment of the agreed consideration therefor.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:11pt;padding-left:0px;"><font style="font-family:Arial;font-size:11pt;">3. </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">The Indenture has been duly authorized, executed and delivered by the Company.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">This opinion is limited to matters of the laws of the State of Ohio and United States federal law. Accordingly, I express no opinion as to the law of any other domestic or foreign jurisdiction.  This opinion is rendered as of the date hereof and I assume no obligation to update or supplement such opinion to reflect any circumstances which may hereafter come to my attention with respect to such opinion and statements set forth above, including any changes in applicable law which may hereafter occur.  Furthermore, this opinion is limited to the opinions expressly stated herein.  No implication shall be drawn from anything herein that has the effect of extending any such opinion beyond what is expressly stated in such opinion.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">I hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the use of my name under the heading &#8220;Validity of the Securities&#8221; in the Prospectus.  In giving this consent, I do not hereby admit that I am in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Very truly yours,</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">/s/ John M. Adams, Jr.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">John M. Adams, Jr.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Associate General Counsel</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Cardinal Health, Inc.</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">2</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>forms-3asrexhibit231.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3D554A932401F6AE8C3AFB26D874603B"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.55172413793103%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 23.1</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Consent of Independent Registered Public Accounting Firm </font></div><div style="line-height:120%;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We consent to the reference to our firm under the caption "Experts" in this Registration Statement (Form S&#173;-3) and related Prospectus of Cardinal Health, Inc. and subsidiaries for the registration of its common shares, preferred shares and debt securities and to the incorporation by reference therein of our reports dated August 12, 2016, with respect to the consolidated financial statements and schedule of Cardinal Health, Inc. and subsidiaries, and the effectiveness of internal control over financial reporting of Cardinal Health, Inc. and subsidiaries, included in its Annual Report (Form 10-&#173;K) for the year ended June 30, 2016, filed with the Securities and Exchange Commission.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:51.37795275590551%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ Ernst&#160;&amp; Young LLP</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Columbus, Ohio</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">February 7, 2017</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-25
<SEQUENCE>5
<FILENAME>forms-3asrexhibit25.htm
<DESCRIPTION>T-1 STATEMENT OF ELIGIBILITY
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sB9D68158C63C167DA16AFB26D91CD709"></a></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21259842519686%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibit 25</font></div></td></tr></table></div></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:100%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">UNITED STATES</font></div><div style="line-height:100%;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:100%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">Washington,&#160;D.C. 20549</font></div><div style="line-height:100%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:Arial Narrow;font-size:11pt;">FORM T-1</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">STATEMENT OF ELIGIBILITY </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">UNDER THE TRUST INDENTURE ACT OF 1939 OF A </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">CORPORATION DESIGNATED TO ACT AS TRUSTEE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">CHECK IF AN APPLICATION TO DETERMINE </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">ELIGIBILITY OF A TRUSTEE PURSUANT TO </font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">SECTION 305(b)(2)     </font><font style="font-family:Wingdings;font-size:9pt;">o</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">THE BANK OF NEW YORK MELLON</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">TRUST COMPANY, N.A.</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Exact name of trustee as specified in its charter)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">95-3571558</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Jurisdiction of incorporation</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">if not a U.S. national bank)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(I.R.S. employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Identification no.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">400 South Hope Street</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Suite 500</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Los Angeles, California</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">90071</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Zip code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cardinal Health, Inc.</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Exact name of obligor as specified in its charter)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Ohio</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">31-0958666</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(State or other jurisdiction of</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(I.R.S. employer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Identification no.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">7000 Cardinal Place</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Dublin, Ohio</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">43017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Zip code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Debt Securities</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(Title of the indenture securities)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s0790B873326A8EE1A267FB26D93E8572"></a></div><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">General information.  Furnish the following information as to the trustee:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Name and address of each examining or supervising authority to which it is subject.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:48px;text-indent:-24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:46%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Address</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Comptroller of the Currency </font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">United States Department of the </font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Treasury</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Washington, DC 20219</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Federal Reserve Bank</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">San Francisco, CA 94105</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Federal Deposit Insurance Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Washington, DC 20429</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Whether it is authorized to exercise corporate trust powers.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Yes.</font></div><div><a name="s1D1BB3597A12CC3643FCFB26D96EBF27"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Affiliations with Obligor.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">If the obligor is an affiliate of the trustee, describe each such affiliation.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">None.</font></div><div><a name="s5E50007534D5BB7B93DEFB26DA06C7BD"></a></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">16.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">List of Exhibits.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the "Act") and 17 C.F.R. 229.10(d).</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A., formerly known as The Bank of New York Trust Company, N.A. (Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121948 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152875).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed with Registration Statement No. 333-121948).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A copy of the authorization of the trustee to exercise corporate trust powers (Exhibit 3 to Form T-1 filed with Registration Statement No. 333-152875).</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">- </font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;2</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A copy of the existing by-laws of the trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-162713).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">6.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">The consent of the trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-152875).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial Narrow;font-size:10pt;">7.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.</font></div></td></tr></table><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">- </font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;3</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="sDD6FDF47FE1B97BB7E03FB26DA0E5278"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:Arial Narrow;font-size:14pt;background-color:#ffffff;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Los Angeles, and State of California, on the 6th day of February, 2017.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:47%;"></td><td style="width:6%;"></td><td style="width:47%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">THE BANK OF NEW YORK MELLON </font></div><div style="font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">TRUST COMPANY, N.A.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">/s/ Manjari Purkayastha</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Name:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Manjari Purkayastha</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Title:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Vice President</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">- </font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;4</font><font style="font-family:Arial Narrow;font-size:10pt;">&#32;-</font></div></div><hr style="page-break-after:always"><div><a name="s047C98B645D047B80F03FB26DA12C26F"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;font-weight:bold;">EXHIBIT 7</font></div><div><a name="sA31AA181A1B6F1A892A9FB26A9BDBA16"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Consolidated Report of Condition of</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">of 400 South Hope Street, Suite 500, Los Angeles, CA 90071</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">At the close of business September 30, 2016, published in accordance with Federal regulatory authority instructions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:86%;"></td><td style="width:2%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;text-align:justify;">Dollar amounts</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;text-align:justify;">in thousands</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">ASSETS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Cash and balances due from depository institutions:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Noninterest-bearing balances and currency and coin</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">2,902</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Interest-bearing balances</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">373,295</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Securities:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Held-to-maturity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Available-for-sale securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">646,702</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Federal funds sold and securities purchased under agreements to resell:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Federal funds sold</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Securities purchased under agreements to resell</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Loans and lease financing receivables:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Loans and leases held for sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Loans and leases, net of unearned income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">LESS: Allowance for loan and lease losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Loans and leases, net of unearned income and allowance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Trading assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Premises and fixed assets (including capitalized leases)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">11,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Other real estate owned</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Investments in unconsolidated subsidiaries and associated companies</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Direct and indirect investments in real estate ventures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Intangible assets:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">856,313</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">57,442</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">125,859</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">2,073,780</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div><a name="s75C5BDF0472657DDE5E9FB26A337D7B9"></a></div><div></div><div><br></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:84%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;text-align:justify;">Dollar amounts</font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;text-align:justify;">in thousands</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">LIABILITIES</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Deposits:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">In domestic offices</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Noninterest-bearing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Interest-bearing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Not applicable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Federal funds purchased and securities sold under agreements to repurchase:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Federal funds purchased</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Securities sold under agreements to repurchase</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Trading liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Other borrowed money:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">(includes mortgage indebtedness and obligations under capitalized leases)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Not applicable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Not applicable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Subordinated notes and debentures</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">287,236</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">287,747</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Not applicable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;text-decoration:underline;">EQUITY CAPITAL</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Perpetual preferred stock and related surplus</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Common stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Surplus (exclude all surplus related to preferred stock)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1,122,671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Not available</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">661,751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Accumulated other comprehensive income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">611</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Other equity capital components</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Not available</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Total bank equity capital</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1,786,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Noncontrolling (minority)&#160;interests in consolidated subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Total equity capital</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">1,786,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Total liabilities and equity capital</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">2,073,780</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">I, Matthew J. McNulty, CFO of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:5px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Matthew J. McNulty</font><font style="font-family:Arial Narrow;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)&#160;&#160;&#160;&#160;</font><font style="font-family:Arial Narrow;font-size:10pt;">CFO</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.</font></div><div style="line-height:120%;padding-bottom:5px;padding-top:5px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Antonio I. Portuondo, President&#160;&#160;&#160;&#160;)</font></div><div style="line-height:120%;padding-bottom:5px;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">William D. Lindelof, Director&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)&#160;&#160;&#160;&#160;Directors (Trustees)</font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Alphonse J. Briand, Director&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">2</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>a1022461483cah2017s3e_image1.jpg
<TEXT>
begin 644 a1022461483cah2017s3e_image1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  O ;H# 2(  A$! Q$!_\0
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M'[)/[</A;]K&QG@L(Y])\06*>9<Z9<D%]F0/,C8<.F3CL0>HZ9]J/Y5^0/\
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M"MF4*=6A!PJ24;6VN[::^>M]Q9IA:U++Y5*=:2E"+=[K6ROKIY:=C@/V&/\
M@IA?_'OXE3^%_&UOHVF7VH*#I$EE&\<<S@$O$V]V^8C!7&,X(ZXK[('3IBOQ
M-^(7P8\3_ VQ\)Z_<K)!9^([&#5]*O[<D+EE5]N?X9$)&1]".*_2'_@GU^V[
M;?M+>"DT76IHH/&NC0JMRA^4:C&!@3I[_P!X#H3GH17M<6\-TJ<%F&7).EM)
M+HUI?TZ/LSR.%^(*M23P./=JFZ;ZIZV]>J[H]Y\?IKLG@W45\,R:9%KYB/V)
M]01WM5DSQY@0ABO7H:^*/VBOV]?CK^RUXOM]'\3Z#X!F>^A,UI<VD-R\-RH.
M"1F4$$'@@@=17W>>17Q)_P %B-&BNK_X43LJ[Y-4N+5CZJQ@./TKQN$W0JXV
M.%Q-*,XRONM59-Z/Y'K<3>VIX.6)P]1QE&VVSNTM5\SWW]F+7OB_XLM_[4^(
MUIX.TW3;ZS66SM-+68W<4C$$&4LS*!MSP,G..:]>J.TB%O:11J %1 H^@%25
M\_BJZK5'445%/HE9'NX:BZ5-0<G+S>K/EK_@KOXQG\.?LI"Q@=D_MW5K>TE(
M/6-0\I'XF-:^3?\ @DWH46K_ +8NGSR*K'3=,N[E 1T8J(\_E(:^M_\ @KAX
M*G\4_LGR7MNC2-H&J6][(!SB,AXF/X>8#] :^-?^"8/C2+P9^V1X<%PXCAU>
M&XT[).!N>,L@_%T4?C7Z=P_'FX8Q$:7Q>_?[E^A^<Y[)KB.@ZFWN6^__ #/U
MJ'2BBN+^-]UX]LO#EO)\/[7PY>:HLW[^+6))$B:/:?NE.C9QUXQ7Y;1I^TFH
M72OU;LOFS])JU.2#G9NW1:L[3&:*^#/C9_P4I^,G[.WBY=#\6>!/"5C?2Q">
M)DEFDBGC)(WJPD((R".QXKTO]CO]J?XP?M3W%MK3>'?!>F>#H+W[/>3^9.+F
M0 981+N()&1RW&:][$<+XRCA_K=1QY.CYDT_3N>)0XCPE6O]5@I<_5<KNO7L
M>W?M0Y_X9K^(/_8N:A_Z325^77_!.3/_  V9X&X_Y>)?_1$E?J+^U <?LU_$
M'_L7-0_])I*_+K_@G*?^,S? V<_\?$O_ *(DKZCA#_D3XWT?_I+/G.*O^1K@
M_5?^E(_7^OC+_@M4?^+)>#_^P\?_ $FEK[-KXR_X+5?\D1\'_P#8>/\ Z32U
M\QPE_P C>AZO\F?1\4_\BJMZ+\T>$_\ !-;]I>;X!+XJ@B\'>)O%9U/R)"=(
M@\TV^S</G],YX^AK0_;?_P""@WB'XV: ?!0\,ZAX(T6]E1KU]01_M=PBL#MV
MX&$!P2!DG &>Q]#_ .")H_XE_C[H?WMI_*2OL+XR? [PS\>/!UUHGB72[:^M
MKA2$D*+YULV.'C?&58>H_E7U.;YK@<'GLZE?#\SBX^]S.ZT6JCM='S6599C<
M5DL84:_*FG[ME9ZO1O?4^8O^"8?PH^$GAEI]6\.^+;;Q;XTEA*2F6!K22QC.
M-RQ0R /@]WYSTX'%?98Z<5^)7B_2M<_9A^.VHV-AJ$]GK/A347C@NX248[&^
M5L#LRX)'0@D5^PWP'^)@^+OP7\,^*'1;=]:T^*YE0'Y4<K\X'MNSBO,XTRFI
M2J0Q_M74C4V;M=:72TLK-;:(]'A#-*=2G+!>S5.5/=+9]&];N]][MGYS_P#!
M1O\ 8IU7X,?$/4O%^BV4MUX/UNX:ZDDB7(TR9V):-P.B%CE6Z<X],YG[+?\
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M//0G'LY[E%#-\+_:^6+WOM1ZZ;Z?S+\5JO/R,ES2ME6)_LK,7[OV9=/+Y/\
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M^R?8OIO[,W@*"0%7CT*T!!Z@^4M<C_P4;/\ QAIXUS_S[Q?^CDK?"N^=0?\
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M_1NQ_P"/*'_<7^5?/_\ P5,_Y,F\4_\ 7>Q_]*XJ^@+'_CRA_P!Q?Y5\_?\
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M\-?$&_\  ]O&DBW7V2PBN)+K=C!#L04P,_=]?:O&H4XSJ*$YJ*?5W:7W)O\
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MU1I&U6[.5!10,LB@D ]RQ/3%?1>J_P#!-/5/B.Z#Q[\8/&WBNV!YMN+>$_\
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&\"?<'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>cahlogocoverlettera01.jpg
<TEXT>
begin 644 cahlogocoverlettera01.jpg
M_]C_X  02D9)1@ ! 0'_____  #_X0!.17AI9@  34T *@    @ ! ,!  4
M   !    /E$0  $    ! 0   %$1  0    !____S%$2  0    !____S
M     8:@  #9!?_; $, " 8&!P8%" <'!PD)" H,% T,"PL,&1(3#Q0=&A\>
M'1H<'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_; $,!"0D)# L,
M& T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,O_  !$( /<"[ ,!(@ "$0$#$0'_Q  ?   !!0$! 0$!
M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M .Z)S^?6K]>2:E\9FW$:9I:X_O7#$Y_ ?A6(WBWQYXI8I8>?'&3G;91; /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#?U?\ &IXY(YHP\3JZ'HRG(- #J*** "BBB@ HHHH **** "BBB@ HHHH
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MI]])&NU'NK5)2H] 6!P*H_\ "">#_P#H5-#_ /!=#_\ $T 7O#O_ "+.D_\
M7G#_ .@"M*FQQI#$D42*D:*%5%& H'0 =A3J "BBB@ HHHH **** "BBB@ H
MHHH **** /DWX]_\E3NO^O:'_P!!KSBT_P"/R#_KHO\ .O1_CW_R5.Z_Z]H?
M_0:\XM/^/R#_ *Z+_.@#[PT[_D%VG_7%/_017DO[1G_(EV'_ %]_TKUK3O\
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MX?\ T 4 :5?)OQ[_ .2IW7_7M#_Z#7UE7R;\>_\ DJ=U_P!>T/\ Z#0!]'>
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M510JWMK'/M!^[N4''X9Q7F'[1W_)/-/_ .PK'_Z*EH \M_X7WX[_ .?NS_\
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MQAR<HS+@'_<.?PKMO#O_ "+.D_\ 7G#_ .@"O,?VCO\ DGFG_P#85C_]%2T
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M&I^+O!"ZIJSQO=&XDC)C0(,#&.!]:\&^/?\ R5.Z_P"O:'_T&OK*ODWX]_\
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M%_Z\V_\ 0S0!XE7V=\*](BT;X9Z%#&!NGMENI"!R6E^?GW 8#\*^,:^[/#@
M\,:2 , 64. /]P4 :=?&WQ;T:/0_B=K5M NV"647,8 P!YBAR /0,6'X5]DU
M\I_M B ?$YO*+%S90^=D<!OFZ>VW;^M 'G6C?\AS3_\ KYC_ /0A7WC7P=HW
M_(<T_P#Z^8__ $(5]XT ?/G[2G_'QH7^Y)_.O Z]\_:4_P"/C0O]R3^=>!T
M?=OAW_D6=)_Z\X?_ $ 5YC^T=_R3S3_^PK'_ .BI:].\._\ (LZ3_P!></\
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M!GTKAOAHAB^*>@1DY*WRKGZ9H ^SZ^;?VD_^1FT7_KS;_P!#-?25?-O[2?\
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MGUWWQ2^(TOCW6D^SK)%I-IG[+%(H#$D#+, 3SQZ]/J:X&@#[-^$__)+/#_\
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M%X=TR-QATM(E8>A""O.OC_IUWJ?@.QALXO-D74XW(W <>5*.Y]Q110!\X?\
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A\S^1M7(&<3QD\GV%?*G_  B.N?\ /C_Y%3_XJBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>coverpicture14a04.jpg
<TEXT>
begin 644 coverpicture14a04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !M 0<# 2(  A$! Q$!_\0
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M8^P)K15(-V3.2>#KPCSS@TN[3L:E%%%6<P4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 (RAU*L 01@@]#7R]^T7_P28^&GQC\1GQ7
MX4;4_A+\0XCYD'B3PC*;"4OD',T*$1R@XYX5C_>KZBHKFQ.$HXB/)6BI+\O1
M[I^:/9R3B+,LGK_6<LK2I2>CL])+M*/PRB^L9)I]4?GAKW[8/[0'_!.4_P!E
M_M">%8?B]\+)?]%_X3CP_:K]H@B8!?\ 3+<@(>.H8+G)P\AXK-U7X1^"M+\"
MZM^T9^R!\4_#O@:&RC-_XBT&\N?*\,ZBH7<T5S;/C[',>@X49(V[,[J_1O4-
M/M]6L)K6Z@AN;6Y1HIH94#QRH1@JRG@@C@@U^2G_  5I_P"">?@S]C35-)^*
MGPKU/3/#^K:KK-J$^'EU;&^L?$URDRL@M[0!MX5B&:)E,8_A*':K?+YOA*^$
MHNK?VE..JN[3AYQGNUY/5[7>Q^]>'?$.5Y_F4,!R_4L76:C)4X<^%Q*W<*V'
M=XTVUM4@N2+][EA;F)O#_P"T]XM_X*B_&?2-<^&FD^%?@+\5/ FA?;M6\4:O
MJ16^U"VDB;-O%;; +BR)\MR\X81AD(P<;^H\$?%+X.^'_&UBGA;P9XS_ &M_
MC^L$<E_?7MZNLV.AW++ET^VR#[';Q(^5#P1D<#YA7S5XV\?:1_P5#3QUX[^-
M/Q,\'_!OQ)\-].;3=(\*QZ1);RN> 5G=OW\Z-(&C,2;G0L3M4</]&_LO?M4_
M&K]IGX1Z)X1_9=^"OAKX-^%DM8TU;Q;J,(%A%<X F-JI4^<0Q.&83.1]X*>:
M\'"8SVE2\I<SEJFHJ4I6TNJ:]V#5M92W_+]6XAX<6"P:A1I*A3HI0J0E5E2H
MT>9<_)4Q<K5L53ES7C1H647=)ZIS]X\8Z%\9O$?AAO$7QZ^-GACX!>#,;FT/
MP=/%;W008_=R:I<Y8/C((@7G(P:\^^#_ ,=/@MI'BB7_ (9U^!WB_P".WBZ-
M_+E\6WL3M ) 2,RZOJ)9UYR?D&#VKFOB3^S[^S?^Q3K">+?VH?BCJ7QM^)H0
M2K8:M,UZ48@?+#IRLP5.F#.VSCC;76^$OVP?VE_VQ=,MM.^ 'PBTGX0>  HC
MM?$WBZ(1E8L\-;VJKLQUX5)5]Q7KNO:KRS?O]E^]J_\ R%/[K'YY#+%4P+K8
M97PKT=27^PX)^22MB<5ZN2J>3/;5\-_M(_$;3I-2\<?$'X?_  4T!4+2VGAN
MR&JW\2'M)?7N($8>J0D>AKR7Q5\>OV5_ 'B)--UWQ]XP^/GBY6*I81ZA>^*9
M974\JMM;8LU^;ML49KH/"?\ P1ILOB1J,&L_M ?$[QQ\:M64K(;"YOI+#186
M!SA+>)LXSZ,H(_AKZL^$GP%\$_ 70ETSP7X4T#PO8JNTQZ;8QV^_G/S%0"QS
MW8DUZM+"8NKK**C_ (VYO_P%-07R;/@<?Q%P_@+TZ%:55KIA81PM/T]M.,\1
M47^.,6^Y\_\ P]^/WQ-\0V(M_A9^S#)X,T>3[EYXPU&T\-QI[FSMTFG(_P"
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M3XFW'BKXV>.[[4[S4O&5O<SW=W#I_P!J_<Q02W(WK*[3+&'(R@B;;C((PO\
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MBW\2/8^(;K4I)-2LS!;JT)CF)W+L/*XZ5\S_ /!.KP3^W'_P5H_9&UB?P_\
MM*:MX5T+P7J]Q;0W-]?W3:KXBO7BCE,,MU&?,2")6C"C)4&1CM.,UZ[_ ,$M
M?^57;XZ?]>OBO_TF6O5/^#1G_E'MXT_['NY_](K.D!S?_!L=_P %#_BM^T!X
MM^*'P@^*_B+5/%]]X(@CU'3M1U.;[1>VP$[6]Q;23?>E4/Y90L21\XSC '?_
M +2'_!+S]J/]H?XX^//%/B+]LK7/A9X2NM7NF\'Z%H;/'%:60D;[.LY22W7=
MLVYQO;GEB>*^-/\ @W;\97GPZ_;0_:Y\0Z=:?;]0T+PGJVHVMK@G[3+#J#R)
M'@<G<R@<>M0?\$:/@A\)O^"MOB3XI_%#]K3Q_<^,_%>D7D3P:+K7B9].L;:S
M>-I&N!&)$_<JV8U5"J1B/D98&F!](_\ !!7]OSXS/^W!\4/V7_C+XQ;XCW/@
MV&\GTS7YIA<3B2TN$AE43X#30R+*CIORR[2,X.!XY^PI_P K9'Q1_P"PEXC_
M /285R__  0/7P%'_P %^?B;'\+8H(?AQ!I&OP^&UAD>2+["EW:K$R,Y+,I
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M1?\ TN-2_L12JO\ P6O_ &SHRRB0V'@]PA/S%?L$O./3WI@>,^,OV?\ Q/\
MM)?\'!?QC\.Z/\1O%/PV\/CX<:)<:_=>&94MM8U&)7 BMH;EE8VZER6=T&XA
M H(#$UZ1\'6\>_\ !/;_ (*I>!?@I+\3O&_Q0^%GQI\-ZGJ6F0^,KX:EJOAK
M4-/59)/+NB [P2(WW6Z%O;)T?@!_RL3?'_\ [)=H'_HX5/\ MA?\IX/V/_\
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M5?"7]I#]H"V^*.J0^+O#_CF.WAM+O4_#7B2\T9]6@A8-'#="!U$R+M PPZ
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,ON^B:* "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gibsonheadera01.jpg
<TEXT>
begin 644 gibsonheadera01.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP"$  $! 0(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(!
M 0$! @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" O_  !$( 80/  ,!(@ "$0$#$0'_Q  ?  $
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MY;F,OU)\EQU>!5Z<)4I7>I;.4F^I3A[P2CIK>GO:9]Z  ,(,U
M
M
M
M
M
M
M
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M-OV,AUXO6?$4SRJE93CB;-6_+6G>U13U$E9-J-,,Y?O!DEPR;5\'19\IEOT
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M;;>HUS:;:@YM68P'B,2><S^'8NAD?,1DHCZD9;?8?7TZERF9&1GY8IVF6P3
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M9GOT_29=?3M^^P\D:)[%]PU%3T6B   ^@
M
M
M
M
M
M
M
M                                   !@"N#[55J2_C_  8:AQ([BD+R
MB[PC&5K(U)5[O*R:%;/MI-.Q\KC=*IIPBWYVEN-J(TJ,AV7[-!IW!QS@RT;5
M%;2A=[!R')I[B5F9.3;?)[9*EK)1$HW/)AQVMB)1(Y"0A1I(MNM_:I-,I.1<
M&6H<EA!N+Q:ZPO*5H+F-SW:'DL*JDK;)*3(S89NE2'"5LE,9MUPU%R#L'V:'
M4J%DG!CH\411^;CT+(<6GDHDEY<VIR:U<66R3/8R8F1UH2LDK5S>9L:%$HP)
M['7R,MBY]^GU4JZ;;'LHTI5R[[]C+J1#Y+*,,I[I$=NVJ8-HW$E-S8R+*KCV
M"(TMI#K;<J.B;&>0S*2VZXV4AHFWD-K61+V4I)Q/>,'X9N7\2^-X90XAK%<Z
M.S,8O)UK,M*6-;27KEB;7E"1!>*JO:%PFV5E[PE3DA]&ZC3Y*?KBD3XSOA6Z
MT\(6G^,YW(XJ]0L[+(\P1B15K4S+L?5#4Y06]W[ZJ2[F-L3Q<E4J,<<F6C_K
MA+OG&2%-F!^GTQ'Y&R;;)"$-IY$M$WY:&T(^%*6T)(B024]4;)V/Y$704;<2
MD.?]^IOV#<<-DL;-26O,<\I)GI%4ND:6S6:"/S34YT(BYU&HDD?4[8_AIVTJ
M?P\:&SYTF1,FSM(M/YDR7+?=DR9,J5BU8_(D2)#RENO//.N+<=<<4I:UJ-1F
M9F*F>)?[==D'\F?_ -3U2 +@O&UO_47U;WVW_J7YWOZEO^#%I\]ORC\Z/V?O
MPR-6>)S3>_QF=J[=:<\-E7FS[^2T&(NM,9-F^8NTM3[S <=)OE:JXE2F(I3]
MNN?#:==Y8E)*=<7*B?HO<;G\#&K?^*_.O\V+05CO8MD?ZF_/U%T->L5D1F1G
MOTQ#%$%M\MBV]/3[>@'A\2GLF.$8KCK^7<,&>:B:>:N8Q!588V^_DBY,&_LH
M)>](KI4V,Q#LZB19NLMQXLR'*77QI"FUSJN<Q\+>>WL[7BMWO$GI?>T^H:"1
MJWI/:Q<<S1\F6HB[V-*1**GR!R$T26F+!YROL:VYC,M(8^D8!R6B;1/:C-V)
MI![(,]B,R(U$1GL6Y;&DC^S?;\PHL> Q'*G\1KC<QVL;\FC*;J&M49HS)EE<
M'56"F$9)0:6R-/O<AA/3G(GE$@R^(P!UOQ'P\HX]>///^'7)]0+["M$-&8MW
M'=QC&Y9PY=\K''*N!=27&W^>%-L[>_E+WL;&'-C55#%CM0XGO+CDM[.'B ]D
MCTYJ*A>0\->H6H&F.J=)$5(QV;*REZ54VL^,GG*-938D:)<U"ISB$ME.KY:X
ML,U&Z[5S6B-DO;^+;[/?J-DNKTOB7X6-0E8#JK-4S/O*-ZRD4+=I;,0F8+UI
M09!%2ZU72[6+'81<U%O&^A[%TGISDQ+K[T5S!9GQR>/[A?6W$XH]"$9KBD9P
MX\C-(=85#(<0AQIGWIK,,3;M,+D$3;A*CHEU%<[-=-).6+9K4L@+6/A24W$)
M6Z,X[&XF)M//U/85(8D+K'XTN?\ 1#:D,5+>2V%=M3S\C-M'/83:OS(SR'&7
M'I+LOWDRJSZ[:BZG^)!Q1YGH1B&=7&GW#-HR[*8S*TQMUYN3E4B+,=J7I,TG
M'&&K"PO;9BQ@XU!L$NT]345LVV=@6$SWAJ5:*X-?$QTZXEM(;K4/2Z=+,Z^M
MM85QC]JRB)D.+Y U3/S$UEK&COOL;J2I*XDZ'*?@SVOCBOJ4APD5U_8KZV-(
MTWUYR-XR<O+C46A8M)JB)4IYF/CYV+"'=]UFA$^YMEM\QF1K>?,NIK,P.V=>
M?9#]+:K%UVN@6<ZB8#JM0PER<>OI>2)DP[>VCLFMJ/:'%BULNH*>XDF3F4TN
M*S#6XE]R%(CMJBJRD]G#\5?+]<\1R_3'5Y9JUBT:L&:6_G24$U8Y%2*?DUD>
MQM6T\C:KVKLH<BHNI;"&D3G%09RFCDR93J[-+A;H/UZ*W^WX3W_/Z"BGX6*U
MT7BP\5-+3-<E1;0\\GV91U;L%+?M\;NW5/$1\O.NYFRE<IE^+>,TIVV( ?#>
MV"7EY5ZN<*,O'&#FWD:1D$JHKS6ZAFQMHV5XL[60GB;>94:),LVHQ[/-'R/*
M(G6]^9,@^'>SB7>N4I6I/&QJOEN>YS:H.:6G^&6AT>!8(F0@UMT52LFY#CYU
MR%ICJ<J6ZV*2T.(<=MC,I[^$?M9VW]7W@SW+<OPAF[EN9;E^'&&;EN74MRZ;
MD9&7<C%[5$<MU=3ZJ,^G?<CW+8RV[;[;=MB( ?GUZ<:;7OA[<>NDVD.!YQD5
MYHMKD5*W+Q:_G^\HAQ\FMK3%V7'T1F8T [3'\BB%9UUQ#@Q)TBM6J#8F^;TE
M:_T%XNYI(S)1&>YF2CWVW/M]Q>A>A=A10\>U!)\2#@I(NA?V/B^$^4RWU=R#
MJ1[*(NI[]OU]+VC2=OSJ_2K]_P#J[ #E    8_<6/\%VI'\@<R_S<LAD",?N
M+'^"[4C^0.9?YN60 I[>Q&?P>:[?RQPO_-V:+Q0HZ^Q&?P>:[?RQPO\ S=FB
M\4 *OGM;NE<*_P"$.^MWV(ZYN'9GAU[7/N(/SF/>IKM%-2PM)+-)R8=FMI7U
M4J)"24?3XLT?9X]3IF7<&N@UE/?.1*@XJ]C2E[&GEBXCD5UC-9'/F(B43%16
MP&]TF9;)(B]!A)[7'JY"Q_A(MZ-^2VS.S;-,0HJ]@S(WI28,QZ^L3;1U-11H
M=:2EGT(C<1UW/89U^SZ:0S<(X.]!ZBP9-F5,P\\F=0:5(<Y,SO;/*H)N(6I1
MI5]%V\!)D9)/X-^1!GR) KZ>SYR7'/$%XUTK<<62+#.DI):S61)1JDI"2^(S
MVY$F:&R3L24;IVVZ"]'*^JG_ 'QDO_\ *C_L^XQ15]GL_P!L'XVO\(Y[_P Z
MAB]5+^JG_?6?\J@ 47O9'Y;CFLW&6E:UJ)&24AI)2U*V-67ZA\RNI[<RB)*5
M'MN9(278MA(=[7\XMOA'-:'%H/\ JGX21\BC3TY+A1&9(^-1)4DMB+^-L9=>
M@CI]D:_AHXS?Y1T7^=^H@D4]L$21<(BCVZGJAA);]"/8V[E1]=M^Y%V,OF>_
M0 8#<!O@R:M<66DND62<36J>08]H_5:;8/5:6Z,Z?34U[$_$:S&ZF'2Y1E\U
MWWJ*Y99%!A1+9U*F)]H:)+1IL*A"4UZ,+?%T\/O_ +W'DNE6O'#-FV7T=3:9
M:5)D>)75LNRKY3L*,W9-199L)BJNZ*\KF[*'9UMJU(D17$M2*V8RIU)1[L/A
M*HVX6.&W[=!=(S^[FP&@/8B^1="(O0B(O05Q/;6T_P!@G2X_7^JFKMT+KBMG
M]G<MNA_(S %P33_.(V38S3Y'"2XW#OJ2MNXJ'-B=1%MJZ/81T.=-B6AF2A*]
MBVYB/IZ#\WS'J77S(O$DXG\0X>KNLQ?+\KL<XI+C-K<W7&\$Q!5MCDBYR.N:
M3YAKN"7%AUE:4>-(E)?G)\@HRMID;]##A,+?233C?_XO,,/I_):J[=3]?M/[
MQ3:\*0C/Q:>*XM^GT5J,9]"/?_3/A/+MO]4TGUYBZGM]X S2=]D"T/N,<FJS
M;4?5C+M3;1E+LO4FPO(JY";@]U*E,TDUB:U(@JD*ZQ+2PGS%,;H39MO*]X3U
M3[*WQ7ZC,9-KOPPZB9'.RT]&;MXL:M+"5(G/P(L+(Y^+7E1'F3%.S%5'TA'B
M6-7$??7]'^\3&6-F7/+:N:J:['O_ !D^GH1ET^X43/9PD[<=/&]_AK+R^WIJ
M]++[MSVW/H74_P X%[H:*[']PU&A]OD /G;NTBP8\B;,DLQ8D5IV3*E2GFX\
M:+'CI6^]*?DOJ0RPQ&0VMUUQU:&D-)4M:B(A^2/Q/<>\/A[XN=9=0N$'.(4W
M&LM*]K4W3=6XY21G<K0S/O8=6Q.0U&LHU#DT9VPQFW\I4%WW1J0V4R(VXM=F
M[VI[C+SN_P STGX-=.)RZQ[5MZEEYE,BOJ;?LHU]D#F/XWC,A2#;4W4^\Q9-
MW<Q_-2=BRU61E*3&*2U)E*S_ -G0T2>X6IO#OC53"K[-++5W U%FPF7\F?U(
M@Q7$1\ON)S:42)+$IQ;];)J6UH@1,>ENUT&.TEEH =*^!%X(]-I6B/Q"ZD95
M&U8UOU$K"ORRQB>=S1T$'*HZ;&0_06KR%.W=W<,25%994M7*[&<^CZ5J/"7*
MDV5G!-G'3(3#-YDI2F%OIB$XU[P;"5I;4^ECG\WR$K4AHW4I\I*U$2U)49$*
M-OLZ?B>Y'HYE]CP.<19N8[D6+7DJFTWL+AXTM1IZWSD+P1V<XKD>K[(GTVV"
M6',4:7'F'6,.+8>IVF_M<NS.5Q%>+%25=!93%X5PW8XMC)'X$Z4B#)L\<:D3
M+.(^N&XVE1EFE]6TLJ'*-Q#[V.SX[C:D&KD NZ-ODKM^LNWH9;>A]-OO',/!
MC&KLK;F+;?TW/H1F1=?A,]R+MVVVZ;GYP I'^VSZA/1=*=%L40LT-76?9!?O
M)(UDIP\8QE4-GJGX#;0K)%+4E9[^8EI:4F2>8K87!%IA"P_1S2S%*Y"6X./:
M>8;4,)2H]N6)C\!!J09I)6QJW41F1*5S'SD1]ZH/ML^G#\S2;1?+&VU*9H=0
M;Z@?4@E*4V>4XTJ9',R+=)-J7C!M*4K8^=3:$]7-CM:<"FJT/--%]*,MK_BA
MY'IWAULRK9)$12:*!NDD)6X:-E[ER&I2FS+RW#)9*(@,M32>VQ'Z;?/;IL/A
M&]-J1NW7D"*>H1>*B-0%72:V'],*@QS6IB&JT-CWY4-E;CJFHGO'DM&ZZ:"W
M<48^[->Q;[;]^A=^F_3]&PQHU$XP],<2R^@T_P HSO%<?S3*V6W\;QJVN8T&
MUNFWYR*QCZ.CR.0I#LBP642,RE?FR'OA:0K97*!5&]M4<6SHSH_R.K8WU0EI
M-;:U$:&_P8F=2,E-F?+T,D\R2^TOK#"OAMX%]8_$T5"U U&S2\TLX:\/B5>'
MZ<XE7DFQLLB_!R#&J[6TCQ9"VZE4MR9%=<GY1<1+-QN<X534P5QX$AYK,CVV
M!\ST6TA47PFC5"<1;F7-NG%9I;IV]",SZ^AD7S(6G> /22DP;1C2[%<<B)A4
MU-@>*1X<<MC,O,I(4N2\XO8E./S)LF1,DN*,S6^^XHN5.R2 C,\4K0*MTH\/
MO4W3BCF3YM1@NB"<5JYMD<0K*3!I$5<&._..OBP87O3K39*>]SAQ8_,:O*9;
M3LD==>RI/O.\%>GBG'%+461:C)YEJ4HR(LXO.5)&HU'RD9F>V_3<]AE[X]_]
MI]Q!?XM[?_E5<,0/92O[2G3W^4>HW^?-V /N_:<EK9X*-9%MK4A7+AFRT*4A
M9<^<XZE1<R5%L2DFI*B_C),R,NH]?X'FE<+4'P_-,<*N94]FMS#3/,L7LI4)
M\F[%B#>Y%F-5*>A/O(?;:E,QGC.*XXTZAM:4&;9I3R'[#VGW^TEUD_O<*_SZ
MQT??^SB_VEF@O\E[C_/7*P!1Z\8#P6M,M!^(?AVTLQ2_SJRH=5)%6Q?3L@M*
MV7;PDR\TCT;JJEZ'5P6(YHBO*<;)]F07O!$X9=R.Z=X<WL]>C_#)J$YJ3@^4
M:DW%TJDLZ X>47-/-J_<[-QA<APV(-+7/JD-G'1Y"CD<I&:C-M2E;E!E[2Y_
M;I<%/_#Z'_G.@B]HZ1FA>WHI9F73J1<Q_P#66WJ *:_CB\;6KFK'$%B' GP_
M7K^)V60,5TO53,H*Y+%A7UUE!*Y54)F1'&Y<&FI\6-O(+M,)UN7;O3Z^K1*B
M-)G-R?O?_L.7AT5B10E9OJ>K.TH][<U$*VK?,5:*0;JIBJ X"H'N7O>\A+*9
M7TF3&R%W*I1>^JQ,\)9A%]XJW%S;7;7F6=&QJ''IG'EFI<:/&RG'<>CK92YN
MHR71-MM$2#226'#)/XO9(O1M1RY=M]OK%L1%REN?HGJ1=.A$>^R3Y2Z "H[X
M!6IG$CIKJCJAPHZU5V79IC6GAO2\)U7E5MM+J(K'-%=AU!Y)8)=*137]9,8M
MJ./(E2WZ:;'L*EZ0IHV6F>3VS[^U3Q/_ !Y8A_F5J0+;YQ2Z'OU3OL1E\);]
M#V3N1%TW+IM]I&*D'MGQ;<*>)E\M<L1+_P#TK4D 8^\'_@IZI<5NG^G.7\5V
MJ.0TVGD/"L8AZ<:&Z=2TU53"Q>+3U\6IM\HL'BF1W[>YB1F+"0VW%EVF[C3J
M[F,V9U3& GBE<#Q^&GJ%I%KCP[YCEM?BN0Y+*JLFPFYME6,:258PS82:U]3;
M,9%Q3W-)](1U1[=#LNKL&X\N%//G(XEYCP]F23H-HKMU+^I1IZ9;[;E_I2JE
M=R(MSW+HHRW(NA=!5L]MA3RZ0:-F6VZM1[HS/UZX;-3M\B(TD1&6W78CZ "X
M\UFD%NB3D$M]J#5%5-W4A^2MM#,.N*)])2)$APR2A+4*)S+<61[<K:U\OSH>
MZ*X+J+XK&J^<91EN8Y/IYPKZ?7"L?QO#\<E%%EY'(=-V1%0\AY+M;(NY4)IJ
MVR2SGQK)-8S*ATU5&(MIB+5GB+W-A6<'FK<RM2MR8C0?(4H)!&:DHD8:4.2M
M!)6@TFF&](61DHN0R4O?T.E!X$<_Q!:W0Q)\,='I3.TYG9ED,MV1E4S'"NEY
M"ABJA6;;[=E;Q);+#;$6$4=!LI2;;ANH,TNI48$I?'-[+WCFE6&6^J_"=FVI
M.#ZFZ?5C^21*P\@>F)R1FECE-EU\2PCH@SZ^W=;8<?B$MZ94RW]J^57DP_[Q
M'F?\ OQ*K3B?T K<MR4HOX<XQ9RL.S545/E,3[2OC1)42[;C<B$1SO*:;%FS
M&$'Y#,XY'NR":Y$(BGGY/XQ,J._%?Q70A;,EEV.Z7ON'$9LNH4VM);WYIZH6
M:2W2HB+ND^N^27LSGAK:S\-6+:L4NKE354YY5D./VU#%J<BJ;V.HH-9+AV3J
MBJG'40MD^YMH2X9&XEI*3V2@EJ K+<=G&SE6AGB0ZYY9@U1)O\[LH4K",$KD
MD<IAK+,QQ&AIJ:>[ =YV[!$"0][PU6&@FYLSR6G>5GS5'82\++V<[)L1U%Q'
MB4U_U;R;+M;H<MS))=&P<.=5U]A9UTZ(]5W-_:ILK&W7#;L7B/Z#^@:Z'*04
M2"4B''\Q^-_2G2FFROQG,S3=Q436L;<M,MKF'2W93=4VG]8=5*<1TYC@29)3
M&"WZ26&E[[$9"_\ MPR3ML?3<E=4EN9[&74RVWV+8BZ=N_-OT \Q">5)%\B(
MOS%L-PT(:@"B7[9+_LMX2OY39=_.F""]5%['_OCW^54**OMDO^RWA*_E-EW\
MZ8(+U47L?^^/?Y50 \D^QB"3VE/^THUQ_P %8Y_GMCXG;/L8@D]I3_M*-<?\
M%8Y_GMCX T]F@_M(M"/\$Y?_ ,Y&:B=T01>S0?VD6A'^"<O_ .<C-1.Z /EL
MU_\ %-E_@^?_ ,C?%&_V.'/J2EC<3R+:WJZQ4G.</-A-C908*GB:1F1.&TF7
M(94Z2.=/,;9*).Y$9D9EO>0S7_Q39?X/G_\ (WQ^83X!W@A:7<7;FN%CJ)DF
MH- _@N7TT*I3A%GCU>U):O59(_,.P3=XSD"W7&U5K*8ZHZXI(2MTEI=YBV _
M2:S'BLTUQVOD6M[GV%T]=&:=?D3;'*J"+'9:;0IQQ:G'+$N;D0DSY6R6M6Y$
MA*C%)WAJU/A\6?BJHU=TQ;D3M,](*'R9>6HARD0K5FKQ>YQJ)))Q;9)9*_O,
MBFHHVW30]/IZLYR6D(-9(D?P+V-[A1JIB)-I=:PY9';6E1U][EU'%C*Y3ZH-
MW&L3Q^:EMS8B<\N4AWH7EN-BQ/PK<&6F>B.+L8=I7B%1AV/M.^>[$K6G%R)\
MHT&A<VULI3K]E;3UIV0<VRE2GR;2325$CH0$+7C$ZUNS\GIL$C.K]RH8:+BQ
M21D27+>Q0M,1#W*?*HXM>VI3:#01H<E*<W/=))AG7S;'L>QF?.?^Z/;8B,]M
M^4NY$1EU(MSVZ#O7BCSU62:D9O<K6MQ$W)+$F%D9&E4>$]]&PC+^*2"AQ6#2
M1$1&2N8]UJ4H^C%ET+]^G3<NHV,^ N$CQO#X&*HZE#'A9<DN[NN2MMWOWEUR
M<>_ZL8KX:5 /&W,RY#E<[)<MJ5\ZZWO:5-+=573\H],=]OBV2D>$KI6F]U,D
M73R/,CXE3OSF>9)*0JRL>6!"^LDR)QIIR9(:41I4E;*5$?PF1VB(B2(C(CZ)
MY4D7HGE21&DNGH>_S/?U$)?@H8TAO'<YMMB-4J]KJLE==R175_O9([[$23M>
M;?;F,U?$9\J=IO4-DGL7H1>OIO\ ,_M/[?F9BG_G;R<LCQ#EPD]QPX4XL-/:
MU&N-D^WLMVV3?S;[OY*UWD[QL<?@L>:6I94K<B?XRME&/[%"$8K[D;P !$Q*
M(    <+K)+[[[>I;[;_+TWZ&1&6QEU(<P #PO<&^;GY2\S;;S-D^9MOV\PTF
MKMT[]N@\I"-OSG\O7[B+]_4;P#__ #Y]ODON^X^))>R2V]O2UW?NP  !].)W
MM^_S(4^O$3_AKSW_  C _F6J%P5WM^_S(4^O$3_AKSW_  C _F6J%@/R=/TO
MF?Q=+^TXY!OGY^BL3^,(_P!ER3#!/UC^Y7_1%M'PNOX%L3_OK?\ G62*ER?K
M']RO^B+:/A=?P+8G_?6_\ZR1)_Y0WZ%Q_P",*?ZC)(Y\A?TM?_ ;?Z[')"
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M?I\MB+MOT^_?YF8XXSAJ+KWZ^FQ^A]2_BGL?4O3Y]1Y(C<D1@AQ.J,BW+O\
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MZ<GKV[Q4%OL^WR1-OD-A*'%9%WQOS);?^3557"*_[W6_NW\VT<X  @4G
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MLOY?K_B)S_W7Y>ONWB4[_ET5U\;17_EGP?WQQ?\ X<C(:_D9:9  %:"Q0
M
M
M
M
M
M
M
M
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M&AP2QN*J]MH]#.L:^[N;2D4Z<"7<9.ZY*O;9<93SOE-3IKS#2'%M1VV6U<A
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MWQ#E<7EU9N)8X6U/V_4L@_MU6Q_6KFNTH_M33TR<>?X'&Y+%MQ,JM3KL7O\
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M09)\MFQBEY:)3)'S+4:GR+REIVQB)1$HR/H9=#(_0S(CV/\ (9'M\CW%[.K
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M_)B^_P"/"$Q/B@*(]%\H(NOX^B_G>(?ZNHAV\(S^%I/\E[[_ (\(>SY?_P"
MGB#_ $^5_9*3R_&K_P".?!_YN/\ U^06F0 !6<L2
M
M
M
M
M
M
M
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MUG;2X)4"*E!%U/D\Y;RS3N:&FEN=D&.]QG'69>3C8M4>JS)OIH@OONLC7O\
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M]]Z^*6MMON9XEV(:C0NQ#45-+0@>,KZWY#_XP\D>$XHR/?T(OUGZ#\R_^_\
M0SY)=O\ ?YE&W._]E-W_ "EG_P ]NB\;3_\ @D;_ (.Q_DD"C9G;I'DUVX1[
MD>0SW4D7<T_3*U=/3<R5TWZ'L?V"\1C$M+]= ?21DEZ%$=21[;DER.TLB/;<
MMR)6Q[=-^W06?_*&BU1P>U[0RD_N;JPM?ZLOY"N7D-)>MS/WSQM?]F63O^3J
M7\I[T-@ 5B+''B26C47*6W*9*)7;Y="V,MC(S[D9ET^?4A6]\2G@25BTB9G^
M(P_]+<MPW;^IB)4CZ#EOKV^DHJ&2,OHF3(7_ %TV:=HCSJW/A869ILFCT]O4
M,367HTIEF3&D,O1Y$=]!.,/L/H-MUEYI25(=:=09H6E1;;&?0]S(9AX)\9Y7
M!YL,K';E7+IAE8_5J&11U;E"7OJ2]ZYI;C))/<7*+Q+QCX0Q^8Q)8]RZ;8[G
MC7I)SHMZ=*2^<'[3A\5O3C+4E0Y(B(U;<II+?EY?J[=.J?[HN;F+?U(M^VP^
MSTWU$N,2O*_(\?FKK[6N=)Z-)2@C3V-+K4EHSVDQ9+6[$EI1&:VU<J>B4F>>
M'B#<#[^F-J=Y1,+=PFTD$F*X2E.G0RWN995,S=)*3$6HE%523-25ME[JZKSF
MT>9&\6_7?H?0_G^;[-MMC(7[X;E\/E\&&31TWXF5"490LBI:VNFRBZ#ZNF<=
MN,HM[_6BVNF11_EN*R^*S947*5.3C6*4)P<H[Z7N%U4NS<):W%^WO%]TTK!.
MOG%U2:K\.^3SHQMP+R [CS-]2N.$:H;YVL(O/9/_ ,M7R%[FP\WS$A7XAQ7F
M(40PX\(O^%I'\E[W_CPA&$W(=0E:$.+;0\A"'TMJ4A+Z6G/,:0\A/P.-H<)+
MQ(7N1/;J3MT,2>>$3_"RC^2][_QX0CGF?!U'"^&?$&/BR;Q[_7RZX/?53ZN-
M"$Z7)OZ\83JDX2]W&23VTV\_X;Q5?RWB'@K\F*5U4Z<:R4?:UUW7SC;K]5RA
M9%-?XRD^R:1:;  %&BYP
M
M
M
M
M
M
M
M
M
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M&A#4:]2]P
M
M
M
M
M
M
M
M
M
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MGM_N5Q73/[#-1GMTWV$W/(7[D7[ Y"_<B_8)"?F_XD;V^4G]RC1BQ2_DI_\
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MMJ<_4<7KMU1TTNR:.?CO)K@\>2FZ;KVGM*^^<H]OG"'IJ2^Z6U\TUV.E=$]
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MOD<7DYQG#*Q9*:E5/HC=*&O3]:/2^OH??MTM]MMZ6MY=B&H ,*,R
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                      -#, #,<?FE\R]?T=^Y$0V+
M=+J1]-OL/[O3J?<O3OT+<5]?$+]H@TDT+S8M*Z:ARK6#57=F._A&G<5N:]63
M'6G76ZNRL"4\2[=3:&WGJ:LA3K&#'<)<IEE7P$!8.\POL_/^_P"_V]!JEPCV
MV]?O^9%\OM_?N*C<OVG[)<+4U/UMX/\ 6W33$'Y$7;*TL/VD.##DO-M-R;$K
M2EH8K+N[K?\ 6J+ Y+AGY;"''C2V=E/A:XJ<$UEPJEU%TXR"'DN)WS#BXMC%
M\Q+C#\=7)*KK"(\E$BNL8+I*8G0):42([Y)+E4VM#BP,D361?O\ ;M\AH3A=
M>I=.XZ3X@N('#]+L2N<[SR_@8UBN/1O>[6WLG%-QX[:E(;:0AM"5O2I4AU:(
M\*%';<D2Y+B&&6UK/I6-3[4'<9G*GR-".$W6C5G%8,J2RK+419%3 F,PU\LI
M<-J!37K:76]R_K.1*1-3S)*2TTLR2 +;Q.E\R[F7YBWZ=.OY-_RC<2MRW^[Y
M_L%?SP\O:$=*M<LR5I5?4&5Z-:MJ>6U'P+4>,5?*LW&XK<OW:GG*;8-=D;"E
M/MT]G$KK&2PA3D-J2WR<T_1ND2?57<]B+<U;$6^W;???IVW+J78 <Y.$?Z?G
MZ=/D-><MM_W_ $_]GVB&'Q-_&XT>X8'JZBR95MEVHEXPR]2Z=X<PU/R22Q(?
M]VC2IA..%$IXDQWF;K_>#5*LW6UE"BOI0:Q%78^TZ9[CL5.2Z@<%>M^*8"HC
M=/*3:EK7!A(-*79=G'LL>K(->VDU$HO?9\=M:#)2'#YDF +>1+(_4OSEZ]O^
MH;QA?P0<=VF7$'A<;/=+<A:O:1]]<.8TMI<.VI+-I"77JF]JG5*?K+!EI:'#
M0LULR67&Y$-Y^,LG!F6VZ2OO+H9&6QD>Q'L?V['^^P Y1Q*>26^YD6Q;]_3U
M/Y[=?3?[=AR'V$+7C_\ $)FFE?"EJAG.GV03<7RRF/%2J[NO)GWN&5AEE)73
M/+\]I]O=Z))>;5NV>W/U[ "9\I"/[I/R[_;M]_?[!KYZ/[I/R+XB[[[;??Z;
M=]Q^>+P)X'XHG$-IAC^K.$\2\*)C>1R+N/7Q[VU@P[-!T-Y.H)9R(\3%)322
M7,KI1M&;IK4REMS9/F(&2&5\,'C$Z?1'LCI]9J'4!V&TX^YCT2;BEU+EMQRY
M_=XE7DV*0XLR1(2E2$-1Y#<E9_4<2[RJ("]4E])]",C[^OR_[2^WJ1[;&1CF
M%8[P&/'DF\2<S(=+M4J"#A^M>&M2Y$Z)71I5?69+7UTM%?9R(]58/R)M/>TD
MU:&+ZI<>?:(G42HBF6_.A1+-?G%_V%]F_P"_Y@!S /'.0GY[[=]O3[#ZEL9^
MA'U/Y#E2K<M_L_?U &\!P$^1[]^AF7U5>A[>I%TW[&1['Z#14A)%N9[$6^YG
MT(MCV[[^I]OGZ=>@ YE*(NI]!L0\E78R/[CW]"/\A]>Q[&(_?%8U6O\ ">&S
M7#+\4M)-)DN-::97<4=Q#\LI-;9PJIY^'-8-YMULW8[J4NH)3:TF:=C(_3 O
MV;+B?S[5[ADH\SU*R>QR_*).7YQ!?N;0H_O;D.OM6684=1Q6([/EQVC-#?XO
M<D[)WV+8 3]@.-;FWYM^WH7YO^L:H<)6^WIMO]FY$?ZC^W\X W@ T, ;/,+Y
MEVW[_P#4.-,E!]E),_D2MS[;]BZ^A]R&$WB.<4S.BFA6JFJ2W&T/X?AEM857
MG?ZV_D#[15V-0E=]O?;^971"^$R2;Z5*(RW(4%N$'Q7^+S3W-.%'4S675W(<
MET>URR2XK7Z>TB04,'4561)PNV?E$U7QE*>CE9U^1US\:0EO9;'F&:4+(P/T
MQB<(^QEVW_)T_:.0>L8<-&W/\1[&1J2G8B)LNN_7?8U;F7?<U;?QB'F^:7?T
M^X_D1_?Z_+[ !S .-#A*+<NVV_8R_09;C:MXBZ=?7L6_;N???8O4P!S -IJ_
MI]/EO^P;/-+]!&73;??Y;GU/["Z@#E <1.==NO;?L1?D[]]O3T[C5;A)[]"^
M?I^7J6WW@#D <'GEUWW+8M]]NFW3J6W4R/?H>PU-TM]O7?;;;K^3KU_H]2 '
M, V)61EN7[^G[_F^T;/.+<B^[L6^V_;?L9=OD .8!MYNF_[]MQQ>>7[>F^WR
MWV/IO^K<^P YP'&EPC/;[OTEN7V=@4YM\_7L1GV_, .0!P^<73[?L/\ 3\AO
M0LC+<O4M_7]1]?S@#>
M
M
M
M
M
M
M
M
M
M
M
M
M                          #0^PU  =(<0<S+F<&S-W3^'$GYXG&+W\"X
MEA*;A5\G*%5<GZ!9FRW4K:8B_2?NYR%K3R^6DRW+N( /9VO"#MM"<6R+4'5Z
MB:/7_.K^Y>OK>QFQ+VRJZ(YIJ8C0K-EV4VAR_EJE75S+CNID3GWXS,ASRXC:
M$6939Z'N9F70]CV[[[EVV_I^_<>(IW;;;YD2"+E^N7=)$2D[D1=#VW,MOA(]
M@!\WG.#5614]C07\&+;TMS$>J[6LGM%)A6%?-0<>7$E1W"-MQM]EQ;9EMN6Y
M*2HE$1BEM[)E*D8[J;Q@Z98\^[.TTQ?.*Z1CZS=6_$@3F[S*J&.IA2CV6[;T
ME7%;D/GNJ0WC\9Q1ER&:\Y?%Q\<=R-;O\,_"U%<U/XALN-_&W).-J;GTNGWO
M:'8UC)E6+2SANY%71S=6XT;Q5N,[+L+V:R]#.O7G]X(WA8PN%321.,39;%SJ
M!E<Y.3:CY%&4ZZQ-OG&O)BU<%U]*9#U70Q3.-%?>)*Y\M^SM5MLJLC:0!!G[
M0W>6>O/%1PS\&46PF0L6O)D#.<]3$=6TJ9&FR;1I).*;Y^234XYCN0NQ#=:<
M9C2[>%,2A2VDD=Q_2K2S'L+QVGQ3$J>!C^-4%?'K*6GJF$PX,&!%;2VPTRRR
M2$D>Q&IUQ1*<><-3SRUN.*4=-N=O:>-*VS/1YC=#IM&*KZ<I,I;TN;FDOF,S
M-S:593BYN_Q\O4T];L<3HVDCZJ)/Q&6^QGZ\N_\ %W/I]A$7H *F7M7W!#77
M&CD;B*QF.=/JCHG>8Y:,9-5[QK65C4RYAUQL2)+!-R'7:*YF5=U525/FNM1'
ML4-%R2U>7./P/<9#.I?#E@NM=HE+?TUIXSE5\A)-MMMV%57R/PC)M)&3<9!V
M-=/Y$I_%LMK:(OJ[GU/XYU4S,X0^(IF0DG&D:6Y#+2C?J4F RB=&<Z]#)M^.
MPO[32?S$)_A99W9(\)K)YZ5_US4:8ZZQH!^49\K4.5D28Q;;[JVYU=2Z*WZ?
M5V '3'LR.C;>ONIFNG&IJ3$1>95:9W*QG!/I%E,AG&N:!'M;257MO)<0Q(A4
MEC08Y42(QM_1\5FVC,[>^?B[LMC5MR8[L64VU*C2&W&94>2VEZ/)8>2IMUA]
MA[S&G&7&U&AQM9&A1&9&DT&9"LO[(O4L1N#FA>;027)^?9Y)D*3U\QUFP:B(
M4H_]RQ$90G?^X(^Q["SU(^KMV[$6WJ?78MOR?FZ>H HS\,F)1N#SQ.;71[$B
M75Z3\1>-MW-+CC9**LI+.9#MK:K;C(<63:6ZG)*&_K*]#*3<CU%M!KMUH:YU
M7EXZM_3U^S;?KN9'Z]3V/?;8^A%L0I,^.XHZKQ">!:X@HY)TRRH:^0X1<REQ
MOZH"(3J#1WY$QK*81'OL27#,NB>MVAE!$9[>JC,_3U5Z;[=_EW/XCZF8 \D5
M^/:?_P"TFUD_^9'^?.."P.*_'M/_ /:3:R?_ #(_SYQP >B]EF69<$.DW;_Q
MIJ81&9EMO_5,RS;[^I]B/KZ"PD^K=*R^'?E,N7N7/Z%T2>VZMMMR/[C[#\W+
MPA=<?$LI= <-KN'C2G#LHTECR\K/&;JU:PI4^4\[EMT]?)>7<:@8]8+*/D#E
MG':4_5M%Y+3:6EO-(0X<D-HKQEM3HR\?D5F!:-PI7-&E7\27@M;*;9>+9QYJ
M757>>V<<TIW0EV!$8F(4OGC*0Z2'VP,6],6V7/&HNOP#Y"K&KB\5EGT5R%$-
MU.CY%E)R38-2.?\ "OW1-D2B29W)2/.(GO,-5Q3Q"_$MTMX9,)+-M3;EV*W,
M?5"Q^@K6FYV0Y/9(:2ZY!I:[S6?-)AHT.3K"0XU6UK;C*Y4A*WV&G8]/!5\"
M>FX7WK[.<IR56H>LF8Q7H]_EKC+R8E;$F3BL+&OIW+!Q^VF/V]@AJ;>7MDZ4
MRT=982;332%$O/;C3\+'1#7C(L&RS5#$D7UUI[/CSJ.4Y/F,1G(424=B]27,
M#SCJ[.@F2^2180Y43S'3:;04I$8GF70*^M-[2;Q%YA%5E.F_ IJ3D6GQMIE1
M;V1)R$I5G 6WSMRZTJ_$WX5FE1MO*-54[/9V)*"=)6YG+GX3_CG:8<5*[G'Z
MBNM\'U'QMIR3>:?Y.;/THB$S)*')L:J4TEMNRB0IBD1;%E34:QK'G&DS(B4.
M)6?UW%'XZO"=HPZ_4Y3J]C3]Q7MK:5C.'>]9?9QG6-V_<'6L;9FP*B2VDB),
M6TFUJT-\J2)*%HWIU\)7&W@FLGBMX;JAI!!MJ+&,V8DP;%NWJHE+-MYQZ?V%
M?D,Z370IDYA/TH_%*0;ZI+K\E])3'B:E+,D 7#/&=\5YKA%T^QW/7\-=S=O(
M,O;Q8JYJX12JB*>I[&S3+]X7&F$M!)KE,FVEKG-;R5ELE*C*/WQ _:;,$TA3
MB&*XAA=GJAJWE.,8_D$C":2Q4F'BCN1U,&XK:B[LHD2PG3;A^).;>;JZNO?E
ML1E-3)7D>?'9<QK]M*/?ATTWW_\ C>@;_P#TH9+_ $#+/V;3PMZK2K2+'M8,
MM@?2>LVKE4WE-SD=R7OUM3XU=(1*H,>@27S<<B-OU7N-K<F1M2I<^8<"0XJ)
M71VB R)XV=<KW4KP]=4<\R7&'\-O<LX>\GO+3%Y!S5.T,N;2RS<K7#L8=?/Y
MV"22E>]0V'=UG\!)V&.OLE+G+P=XZ>QF?X=:B$1%\_IIG\Q?;L>WW=2DP\:U
MO;A)XC3WVWT@S;KL9E_XFD=^7J9]"(C/H@O0T[BK%X7GBJ8OPH>')3Y=8^[V
M6:7N=ZFU.G&*/FHCO[]%I'6J;+2A1.,X_0>:Q.O)9*1LDX]<RLIMA%W GO\
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M"2T!M2K?]_L(;@
M
M
M
M
M
M
M
M
M
M
M
M
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MV\;2_+>3.15TRE03B*DH-Q<)YI:F8O.41@#,SVTHMN'/3<M]_P"R[ V/U/\
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M_-^3L-P
M
M
M
M
M
M
M
M
M
M
M
M
M                -BFR/H9;E\C(C_60X_=F_P"X1_[*?V?OZ#G  <'NS?\
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M9)(C/N>Q;GO\SVW/[?GZC?RE_1Z>@W  !
M
M
M
M
M
M
M
M
M
M
M
M
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MD7*HNO7?T^+8CZ$9;'WZF1D7<OD!Y0#0AQ..\NW0SWZ=-OEOZGZ^FW]'4#F
M<+;O,?W;>I?(]^FQ&74MOM^X<P
M
M
M
M
M
M
M
M
M
M
M
M
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M@
M
M
M
M
M
M
M
M
M
M
M
M                      !H?I^_H8HO^RD)(M=^-HN4C3^%%07*>Q),OP^U
M0+;KTVVZ=>@O0'Z?OZ&*,GLHA?V>N-G^5-1_G]J@ .;VG?@\R72?/].>.?2%
M'N.0X;>4==GYLMGRN2(;J(^+Y%8);,C>A6$4W,+R(U[$Y#>I4'N;\I:94_$#
MXO,9UW\.?5#53$W4JJLLTBG2W(VZ3=J;5B?6Q;JDE$1GRR:BT:DP'/K<Q,)6
M2U)4DSGBU\T3Q[4?"\FP/*X#=GCF6TLZAN(3B$J)Z%81UL.&V:NC<A@U)D17
M2^)F2TTZDR4DC+\P4M6\GX0Z'C.X(]2Y[QXUD^)6UOIQ92&W%1YE^MRI?I;&
M 1;(;B9YBC<<IAM<Z(E]3Q8;B4.IG<@%Q[V4Y6W!/IUMW_"#4?IOM_[_ "\Z
M[_9Z_F$,/B:75-Q,>)+A.@VH=U$KM&M&:R/:9-5W-O&I:JUG+H(^76R79$F5
M$;=<NCL\9Q\]G4R6ZI-DB*I"G'$G,Y[*BKFX*=.S21%OD&HVR2+IUSJZ-2=N
MR=]NA%N22,NIGN*W&OG 3IQJ[XK&IVEFLZL@8H,_AJNL7>IK)-+,G6WX"8W:
M5J6IS\28AV*VS69'")E+*B7)A$V1D;:FP!?(H-7=$ZNB8QJNR?3&!C\6"BMC
MT,3(,/CTS,!#2640D53<_P!Q**EI*6R9-I2?+(DGN0I::$.XMPW>*I78SI5:
M4Z-+-<Z;W>328W;0)E%!D9/53ID>OCM5LB5"CG5YI4)E5<=24.Q:^RD18WE1
M9>RI6T>Q\<(1D1\FJ1;]=OPXB[?/8C/'2/H7?<M_RCO?A=]F&X9M),_Q/4O$
M2U%/(L-N6;RE.TRZ-.KDSHJ5^2<N&BB8-]DB6HN5+R%[F1\Y'U $6/M5^-2M
M,-4^%;BKI$N,R<0RQ&+7DME!*=\NHM&<RH&4DI/X[WB#^&S*DK,NBVDH/H9"
M=?QM>+6-@W!UJIG-/-0VK(\%8IL9?V4:WG]0BBT]>;7EGS$OZ-M9+S:TJ+E-
MGX5>I?#>TA<,1ZG<(>J,..P;]GAT.%J%4$AA4A[S<2DHF6#324%YA.2J-=G$
MW3V2LSV/85(^+GC'FZ_<&_ ?H/5SG5Y-J!FR,,R1,57O#[3>FMG&P*LD3F4$
MISS);-_59,GG2DO)9<5ORH69 ?)>"7IG;\+?%1PKRK]YY%-Q.Z+(GN//;QX;
M3V;.7,BBKT$D]G78ZJG%.;S4\R9-ZH_A2HR3.3[8AK3+_J4:5:,4AF_>ZK:C
MPWB@QE*5)DP<?:*/%C^2E1>8W,R"_@>2E1'YCT))),E-&9_+>U9Z&KT^P3AO
MULPR$S$F: Y_0T\$V.9IN'5DBOLZ%LF.J?)9N<2C-)W/E0E]*-]U[*Z?UTS*
MOXJ_$^X?*NI6FRP;2C3[%=3G^1)$EA;U.UJ;!>=4DU)7YUG=8(RM*C(N1XT\
MQI-LE 7+^%30R%IEIO@NGU<AA$/"\3H,9:.,VEIIY5/6184B42$D1$J9+:D2
MW#VW4X^I:NJC&0(X&?R^O?\ 3^K?\OV#G '&Z73\Y?G(R_?Y=_04O?:S> VQ
ME8YB'%9I]YM9G6D<VJBY'85K9(G.8W]*MRL<R(W$-*=.5B&1.-J2;FY(@VKI
MN[M1D(%T80^^/JG_ %'?$%_B[LO^75H JW>S@:"Y=Q0\1&H7&OK 3$Y^FM5P
M\;041UFM7FC]:Q%0=2PZMTVJW!L83%@U[9NO.IE3XKCCIR6UO+O_ );\JMMB
M4K?;?J1%ORHYNVYD>QF70RW/?J*K'L<Y?ZDR9_C:SC^:\/%K&0E.Q&9D6RT'
MU,B[*W^SL1&?Y.O;H!0DT8T]B<;?B8:F6&?-IR'2SASBS85#C4]*GJ63*Q^Z
MCTU36SH$@W&'&K+(WKS([5I;9-V/T6F%*2XTI*2O*97I7CEY02,7N*"GM<;E
M0UU\JAGU\&32/P5(-E<5RL=95"2RII2D<B&4\A+,D\IGN5*KV< RQ/C9XVL"
MMB\F^D65[;1D+,T+<@U6I-LN0M+;A)<6:D974N;DDR)*N;FY329WG6S3L9]-
MCW/?IZGU/U+8^G7M\@!1&\)J!+X3O$4U>X6JJ3)/3'4"$[D&*5TN5(=9@OHH
MXV7XR[&W/RW9<:JE6.*3Y:D)5**$WYBU%&:Y>FO;-,CMZ?5+AIM\>>DQKZLJ
M<JL:21#;)V6Q;PLMQ>56/1FS0X3DAJ:TPXR@T+);J4IY5$?*?>^I+#6;>-'C
MK-.XE7X XO6N7;B%DIOS*W327826^9!FG=I%_"C.)5MRR$+:41.)-)<GM1*"
M_P"Z@X(4F1&7X2L$9&1&1_V3L%(R,CZ'OZD?0P!-WX-O@LX'H)I]4V66X[5Y
M1K7E$1N[U%S+(X<6[MFKRV)-A-HJJ3/;D^Y5M4\][M(=BJ]XN;%N5:2WE^>T
MVSC=[78TE/!M<DE)$1:@8'L22))=)THB^PBY>A;;;="["SWREN7[^I_F_(*Q
M/M=Y$?!S<$9D6^H.!EUWVZSI?RV[=SWZ;$?8]C &)^<>,?2\*7 +P]IJ'X5C
MJSF.CV-P<"Q]TTNIA$FM-B7F=NR25?Z#42NL:.?Q7%M[M7I(F$SWH_=WLW7A
M0GA6+.<2VJ4Y&8:U:TP/PD9NWYC-H[CF+Y&HK$FVK%+C[$B_RA+K=AD$UM9^
M[13BT,3RD,61S(,/"K]GRR[B8TBM]6M<;^X;<L=,BPGAWJGY"VT5$&GA.1<5
MR>>RTXP3..PWV2C45/RDBR:EV%],WYXCDF4?V4'CPN"J,UX1]3%/5>=:/V-N
M]C%=9.+8LE8\W;/1\HQPT25<ZGL1OU&[';/9:*>W2RRVB'5FH@+H$8MDD77I
M\.ZM]SY>F_7KU^?KW[#G'C-.IV[EV)6QF1&1'OMN1[&1=#VW^1_(<WF)^9=^
M7N7?;?;OWVZ[=]NNVP W@  "/KQ7O[6G7?\ Q49Q_,4L0B^QW?VHLCI__%O-
M3W[&6U7B?\;TW]2+;<N@FZ\5[^UIUW_Q49Q_,4L0G^QR%_J197^-K-/YKQ4
M1(<<6-3/#LXY*'7C&X+S6A6MDR<C+*FO9,HD!%G+8<S>C8CLH3&1(JIZF,VQ
MB.DF]V3D53'(VPM8D&]L8RBNN^%#3NYJ)L:RJK;53%[.LL8;J7HEA7S\-RF7
M"FQ7D? ]'EQGFI#+J#-+C3B%I/91"=SQ=O#TJ>)C0[+M-926&+YZ,5UA%H\D
MDG49K5-.NT<E3W=N',<4Y46W*1J^B[&4M"5.MM#\T#B$X^;BVX-V>%G4<IL#
M470_6J U3PK%"BDKPZ/59A7SZ5\S3O[YAU\Z4)OF-*2J;&&TRI2(YD /U0O#
M]+?0G1C_ !3Z;?YDT0[!XH.'?'-5]/LNTXRN(B7CV8T4ZBLFS02EM-S&C2S-
MC;_5FUTGR;""O<C;EQF5$:=MRZ_\/P]]"M&#_P#DGTV]"3_[R:+T+H7W%T+L
M0R\67]/ZC 'X[F3X!Q"XUD=[X=$:6MV':ZZ5,QJO\F229ULJ*4*NN6GE*Y_P
M3MJ=ZJS26T;*V]ZR+8->5^/2_P#JY<$G";C.A^EF$Z58HRV5/AM'%K"E$RTT
M[:V'5ZYO)B6R))S;NV>EV<H^I>;)62#Y.0BH^:VE_P#;M*'_  Q@W_,-5#]"
MJ,6R&_\ >T_K( >422+M^_?]HW   T/]GZQ7;]J=_M*-4/\ ".!?Y[THL1&H
MMORD7<N^_P!__6*[?M3RB_[BC5#_  E@9%U+O^&U*>WYBWV[[=0!F1X&/]J!
MP[?XKL;_ ,@8E2G+Y4+41=D+41_(TH69'^0]OSE\ND5G@9GMP@<.V_3^Q;C1
M]>G0XYF1]?0RZD?;;KV$JLGE-)I5MLK9)[^A+(R+?;?;KML9[%T/J *3_L7;
MOTKA/$#DTK=RRO=2:1<UYSXUKYZ.7:*,U'N:E.2I[RW%']8]E'U%V4F4\QJY
M2W/8C/;T29F7YC,S+[127]DXDHP+4#BZT+GM^Z6.'ZA,3X[#JDLK5#JK3(,3
M?<9CK,G3:0B# =6\2#:\B5$<YN1YM2KLS1EU5L74S,S(]]]NGH>W3J7Y.O8
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M+,?;Y%;&GRW7EHY3+=)%RGMML/OP
M
M
M
M
M
M
M
M
M
M
M
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M/ON7W['4*-6Y="Z=25RFK;?X3V+?8NY=>YGT^8&-\[4UW(]*Y.8XPU;PG[O
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MDQ;W=1OZ$?4NY\O7YD9=2,NY;;']I#B4ROK\:NNQ=#VVV[F7VF73H?;KOOU
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M.-LC(NWH78]QR
M
M
M
M
M
M
M
M
M
M
M
M
M                       \-R-N9GZG_?;&6W*9*(C(SZ&>VW8S&U$0TD9<
MW-ON>YI+KT(D\VW?E(BVVVW]?4><
M
M
M
M
M
M
M
M
M
M
M
M
M
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MP@54#4BR=FV<Z'71&_P+R9OS),Z2U%80;CD-M#9*==02G%*)+:=UGT(P!88
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M< 9B -"/L-0
M
M
M
M
M
M
M
M
M
M
M
M
M                &FPP*\4XO]33K]_B;U']3_\ O2M1GL,"O%._M:=?O\3F
MH_\ FE:@"N;[%,7^IXU._P <\O\ S!P@7)3V[;_I^77_ *Q3;]BE_M>-3O\
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M$J'&8)7EPJTZZ"RE#+339=E>U=YJ=3P8Y['+;>^R/ Z4^AD?*>11[3IOU_\
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M%R)^D>G$F0MU1+<<DKQ*H)]Y:R,R4IY:%N'N?-\7Q;*W(9L@
M
M
M
M
M
M
M
M
M
M
M
M
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M\LFM3<1==Y&&6UN*\MMM:U<J3(D),^A$>P&0?L_O]IKP]_R#;_G6Q$Q0A[\
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M>I[%MU[GZ^I]1S
M
M
M
M
M
M
M
M
M
M
M
M
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M4DGZI)3_ !$D6R"W).Q&9'Y0
M
M
M
M
M
M
M
M
M
M
M
M
M
M        -BG"+;<R+?IUZ 3B3[&0 W@.(GDF6Y&7Y_MV_7T^\<A& -0
M                  S''YJ?[HOSE]A_T@#D ;"<(^FY?G+T[_N0W@
M
M
M
M
M
M
M
M
M
M
M
M
M
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MV5I/G%3FK&,S(L"^56)F-+K)<UMYV(U)9G18KR?>4197DK0A;:SBOI)7,@R
M&80#H+B5XH,"T?Q.=G&I.35^)XK7/PHTNXLO...W(L)"8L)@D1FGWW'9$A:6
MVT-M+5W49$A*C+V?#YQ#X9JIB53G6G]_"R?$KU,I=3=P">*-,3"F2:^5R(D-
M,OMJ8FQ)$=:'FFW"4T9\O*I)F!W4 PTXI_$$T=T3EXQ U1SJJQ";F<B3%QB)
M.:GR)%P_"<@LRD16H$.6LB9>LH+1K>)M"G)"$H-1DHBS';7S;_89E^4CV/\
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M$.RMX,6 I;KCJ6FR>D,$ITC;WYN4C FI <;:^8M]C+[#+8R^PR]#+Y>G8<@
M
M
M
M
M
M
M
M
M
M
M
M
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M+;1%?"P&_7<45);+(FW+:GK+)2$;&E*YL*-*<(C-*=^4W#2E6R>A_5(Q3O\
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M\X.8B<\
M
M
M
M
M
M
M
M
M
M
M
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MOAU=;#0X\Y(<1%@0&(\2.E;[SKRTLLH2IUUQQ1&M:U']4
M
M
M
M
M
M
M
M
M
M
M
M
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M@ --OWW,:@  ;    --OWW&H #38:@         --AJ   --AJ  TV&H
M                #3;]]PV&H  --OL&H #38:@
8                            #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>locationfooter.jpg
<TEXT>
begin 644 locationfooter.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0 Z17AI9@  34T *@    @  U$0  $
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MOP;#\$O$EXVH>9+-OM=\UBMC(KQR8/F3B,AB&;J*_3JB@#\B[K]@/X@?#_\
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M_#'PS_P1\_98\#_M1? CXFZII.F:&K7>LV7AG4'OOAM?VX\Y'N?L175K RE
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MX:\>0^$M235=)75K7S?LDZLK$=MT3[$$D+YBE"*LB. !7JB(L2*JJ%51@ #
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MQ!X<\06KV.HZ=?0B:WO(7&&1T;@@C_'K6%^SA^S7X%_9$^#6B_#[X;^&M/\
M"?@_P_$8K'3K3<RIDEF=W<L\DC,2S22,SNQ)9B237<44 ?&O[</PO\3>+?\
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MKIFFS79TC3[=;OS[RX$:GR;>+<N^5\(FX9(R*^[** /F2Y^$.K>+_P#@I/\
M%^XN-/UBQ\-^)O@QX<T"#61:R"U>Y&J>)3-%'-@(TT4=S"[(&W*)8R0 ZD^#
M?L??\%#?^&3?V(OAW\$=7^%_Q,U3]HSX<>&[+P9!\/K+PY?A==N;$+I\5Y%J
MC6_V!--F$2W#7K2F**)V)W.NQOT4HH ^'Q\)_%7_ !$C_P#"=?\ ",^(/^$)
M_P"&:O["_P"$A_LZ;^RO[1_X2CS_ +']IV^5]H\G]YY6[?L^;&.:]/\ V/?
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MSM@X49)P<"@"]156]UNSTV]L[:XN[6WN-0=HK6*255>Y=5+E4!.6(568@9P
M3T%-O?$>GZ;K%CI]Q?V=OJ&I"0V=M).JS7?E@-)Y:$Y?:""=H. 1F@"Y1110
M 452_P"$DT[_ (2+^Q_M]E_:WV;[9]B\]?M'D;MGF^7G=LW?+NQC/&<T_7-<
MLO#&BWFI:E>6NGZ=I\#W-U=7,JPPVT2*6>1W8A555!)8D  $F@"U16?X3\6:
M7X]\*Z;KNA:EI^M:)K5I%?Z?J%A<)<VM_;RH'BFBE0E)(W1E974D,"""0:T*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?"WX5_"N;XG0^'KY%N--UC7+S4Y=*ADO;:0-%.MO;17!B#+E7N&.<$@^^_\
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M3->OO%WQFO[#X?6]QIVC3:E;Z3:ZE<I!?WE[Y:M]GM(['[5OG?"HS(-P+ T
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M"?WP9_9A^-'CKXB> ?A[H/AGQK\29S<^(M5ME=IKYBV]PH9BL*/)\[I"$5W
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MM*?!#]KS3UU*V\-:QX"\,:Z%\87<;&:PN);O2XIM(N[6[<0&X%VWF*#*CD%
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M+F"088!T*NC=PZ,&4@$$$ T44 ?.FM?\$GO^%@^ X_!OCO\ :,_:4^(/@.6
M6>J>'=6UW2K6'7[79L:VO+NQTZVOY8I%XD N09 6#E@S _65M;1V5M'##&D4
M,*A$1%VJB@8  [ #M110!)1110 4444 %%%% !1110!XGH_[$6FG]I^W^*GB
M3QU\0_'&I:'+>3>&-&UJ\M%T7P@]TCQ2O9V]M;0EI/(DD@66Z>>1(I'57&]R
MWME%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %>._M0_L9Z;^TSXG\(^
M)(?&GQ"^''C3P.+R#2?$7A#4XK:[2UO!#]KLYH;B&>UN()6MK5RLT#E7MHF0
MH022B@#!^#G_  3RT/X>_'FR^)_B[QU\1?C'X\T.PGTSP]JGC6ZL9%\+07&W
M[5]@MK&TM;:&2X"1K).8FF9(PGF!"RM] 444 ><^ _V8M!^'G[2_Q"^*EE>:
MQ+XA^)6FZ/I>IV\\L;6<$6F?:Q;F%0@=6;[;+O+.X.U,!<'=Z-110 4444 %
M%%% !1110 4444 %%%% !1110 5%?6,.IV,UM<1I-;W"-%+&XRKJPP01Z$'%
M%% 'R=X<_P""3G_"!?#^/P3X5_:._:6\)_#VSC-GIOAK3=?TORM&L 2(["VO
MI=.?4HX(H\11L+LS1HJA9 5##Z0^#'P;\,_L\_"7PYX%\&:3!H7A3PGI\.EZ
M581.[K:V\2!$7>Y9W; R7=F=B2S$L2244 =-1110 5@>#_A?H/@+Q'XJU?2=
M/6SU+QMJ<>L:W-YKN;ZZCL[:Q20AF(3%M9VT>U J_N]V-S,S%% &_1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
